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Abstract
Human Papillomavirus (HPV) was the most common sexually transmitted disease in the
United States in 2018 according to the Centers for Disease Control and Prevention
(CDC). The CDC established the Healthy People 2020 initiative for HPV vaccination
uptake of 80% to effectively eliminate HPV associated cancers. The project site, a rural
multispecialty clinic in the Mid-Atlantic United States reported a 3% vaccination
compliance rate, well under the national average and the benchmark of 80%
recommended by the CDC. The practice-focused question for this project was to
determine how education of primary providers will increase recommendation rates for
vaccination of HPV. Pender’s health promotion model provided key elements to
evaluating barriers to vaccination and developing strategies to overcome barriers to
recommendation. The search engines and databases used for the educational framework
on the vaccination recommendation improvement project included CINAHL,
MEDLINE, ProQuest, and OVID Nursing Journal review. Search terms included HPV
vaccination, adherence, vaccination surveys, education, primary provider, health
promotion, advocacy, and immunization barriers. An urgency statement was developed
as a 1-page significant information sheet on the facts about HPV, vaccination risks and
benefits, and barriers to vaccination. The vaccination data report obtained from the DNP
project multi-specialty site revealed that post urgency recommendation had improved
from a 3% baseline recommendation rate to 100% for the in-office clinic visits. Vast
positive social changes can be made to promote health as it relates to HPV infection and
elimination of HPV associated cancers globally.
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Section 1: Nature of the Project
Introduction
Human Papillomavirus (HPV) was the most common sexually transmitted disease
in the United States in 2018 (Van Dyne et al., 2018). The Centers for Disease Control and
Prevention (CDC) established the Healthy People 2020 initiative for HPV vaccination
uptake of 80% to effectively eliminate HPV-associated cancers. Both men and women
are being diagnosed with HPV-related cancers despite health care initiatives and provider
awareness campaigns. With 14 million new cases per year in the United States alone, the
American Cancer Society has made new a new goal for the year 2026 that would support
that 80% of preteens 11-12 years old will receive the vaccine before their 13th birthday
(Fedewa et al., 2018). In efforts to identify the barriers to meeting vaccination rates
community leaders around the world have made poor HPV vaccination rates a global
pandemic priority (Fedewa et al., 2018). Cervical and oral cancer diagnoses continue to
reach numbers larger than 500,000 per year (Senkomago et al., 2017). There is
significance in HPV vaccination as a public health problem because after more than a
decade of HPV vaccination awareness, providers are still coming up short with
recommendations to vaccinate (Niccolai, North, Footman, & Hausen, 2018).
Recommendations to vaccinate have been identified as the most significant predictor of
vaccination adherence among the preteen population, demonstrating how a providerfocused project will create social change (Niccolai et al., 2018). The DNP project was to
create a platform to assess the barriers to HPV vaccination recommendation in the
provider population and then deliver evidence-based urgency statements on HPV
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guidelines that in turn will increase knowledge and reduce or eliminate barriers to
recommendation. Section 1 will present the problem statement, purpose, significance,
nature of the project and summarize the project objectives as they relate to creating a
platform to educate providers towards recommendation of HPV vaccination.
Problem Statement
HPV infection is recognized by the CDC to be the most common sexually
transmitted disease in the United States, with more than 14 million new cases confirmed
every year in the United States (Cole, Thomas, Straup, & Savage, 2017). Our local
problem focus is on assessing barriers to recommendations for prescribing the HPV
vaccination within the primary provider population. Conducting a vaccination adherence
project in a multidisciplinary clinic increases the feasibility of vaccination, as these
clinics have certified family practice, internists, and pediatrician providers. The MidAtlantic region falls along a religious beltway in the United States that sets precedent for
religious beliefs to impact vaccination adherence. Although categories for exemption
include medical exemptions, in this region these exemptions only account for 0.4% of the
total 4.1% of the total nonimmunized students, with the religiously exempt students
making up the largest group of unvaccinated children in the county, at just under 2%
(Capps, 2019). The project clinic identified itself as religiously based, and the providers
reported affiliation to religious barriers to conversations that were in any way connected
to sexual activity. Also, anti-vaccination protestors had strong emotional responses to
risks related to vaccines, and providers had knowledge gaps about the risk-benefit profile
for HPV vaccination specifically. Any decrease in vaccination adherence has been proven
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to have a direct and inverse effect on risk for transmission of the disease (Capps, 2019).
Perhaps the most significant measure for poor vaccination in the region is lack of access
to care. Lack of access in this region can be explained by the rural nature of surrounding
counties. The county health department reports that there are higher numbers of parents
reporting lack of access to care related to time and travel to care centers as compared to
anti-vaccination philosophies (Capps, 2019).
Evidence of a global pandemic has resulted in the CDC recommending HPV
vaccination penetrance of 80% in the population as part of the Healthy People 2020
initiative, but efforts have proved futile as actual vaccination rates remain closer to 57%
in the United States (Sussman et al., 2015). While researchers evaluate why vaccination
adherence remains low, there is growing concern about HPV-related cancers. There are
33,000 cancers caused by HPV every year in the US, with an associated cost to treat
noted to be greater than $7 billion (Fisher-Borne, Preiss, Black, Roberts, & Saslow,
2018). The World Health Organization (WHO) data indicate that despite vaccination
efforts and screening these numbers are now globally reaching 570,000 HPV-related
cancers in women and 60,000 cancers in men per year (St. Laurent, Luckett, & Feldman,
2018). If vaccination rates reach the 80% goal, vaccine models suggest that the HPV
infection would be completely eradicated, and cancer deaths could be reduced to 20%
globally (Brisson et al., 2016).
Purpose
Although many socioeconomic and behavioral factors have impacted the
vaccination rates for HPV, it is the consensus that involving clinicians, parents, and the
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adolescent patient in the discussion around vaccination will improve adherence (Cole et
al., 2017). Lollier, Rodriguez, Saad-Harfouche, Widman, and Mahoney (2018) described
how primary provider knowledge and support is a common theme to vaccination
adherence and disease prevention. The project site has reported a 3% vaccination
compliance rate, which is well under the national average and the benchmark of 80%
recommended by the CDC. Although there are ample providers in the project site
provider group treating preadolescent patients, poor vaccination adherence is a
multifactorial problem. Vast social impacts can be made to positively promote health as it
relates to sexually transmitted HPV and elimination of associated cervical and oral
cancers locally and around the world. The practice-focused question for the identified
problem of poor HPV vaccination rates was, Will educating primary providers in a
multidisciplinary clinic on the current state of HPV result in increasing HPV vaccination
knowledge and recommendations for vaccination of eligible preteens to 80%?
The practice-focused question was to determine how education of primary
providers will increase knowledge and recommendation rates for preteen vaccination of
HPV. There is significance in HPV vaccination as a public health problem because, after
more than a decade of HPV vaccination awareness, providers are still not meeting the
recommendations to vaccinate (Niccolai et al., 2018). Recommendation to vaccinate has
been identified as the most significant predictor of vaccination adherence among this
population (Niccolai et al., 2018).
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Nature of Project
The search engines and databases used for an educational framework on
vaccination recommendation improvement project included CINAHL, MEDLINE,
ProQuest, and OVID Nursing Journal review. I also consulted trusted websites including
the CDC, National Vaccination Advisory Committee (NVAC), the WHO, and Advisory
Committee Immunization Practices (ACIP). Search terms included HPV vaccination,
adherence, vaccination surveys, education, primary provider, advanced practice nurse,
nursing model and theories, health promotion, advocacy, lack of access, and
immunization barriers. Clinics with specialty providers have an inter collaborative
approach and are increasingly likely to appoint vaccine champions, use standardized
policies, and schedule appropriate time to visits scheduled for vaccination (Lollier et al.,
2018).
The approach for the DNP project was focused on applying advanced practice
nursing principles to make meaningful impacts in this area by disseminating and
translating research. The use of Pender’s health promotion model (HPM) provided key
elements to evaluating perceived and actual barriers to vaccination and develop strategies
to overcome barriers to recommendation (HPM, n.d.). The medical director provided
oversight of the process in which the nurse vaccination champion provided vaccination
data on how many vaccination recommendations occurred from participating providers in
the month prior to my initial visit for pre-education preparation. The champion was a
designated nurse trained in vaccination procedure who had access to an electronic
database from which she obtained statistics on provider recommendations, numbers of
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patient visits, and percentages of adherence to HPV vaccine recommendations. The nurse
champion created and then printed the deidentified worksheet for me when I arrived for
the pre-education phase of the project. Prior to my pre-education visit I made a project
initiation visit and delivered the providers a pre-education survey titled “WD4019: You
Are the Key to HPV Cancer Prevention-2018” to identify barriers to vaccination
recommendation. The paper survey was adapted from an existing approved survey from
the CDC, took less than 5 minutes to complete, was delivered to the nurse’s station by the
nurse champion and collected with no identifiers (Vaccines CDC, 2019). Providers
completed the de-identified surveys and returned them to the nurse champion who placed
the surveys in an envelope titled “Pre-Education Survey” and kept the completed surveys
in her locked, private office until my return for the pre-education visit. The vaccination
champion obtained the vaccination recommendation report and provided it to me during
my visit in a separate envelope marked “Vaccination Recommendation Report”. All the
data were kept deidentified and secured in the private office of the nurse champion.
I collected and evaluated the data report, the results from the pre-education
survey, current literature from the CDC and current peer reviewed literature in order to
develop an urgency statement. The urgency statement was a one-page statistically
significant information sheet on the facts about HPV, vaccination risks and benefits, and
ways to overcome barriers to vaccination. The urgency statement on HPV and
overcoming barriers was aligned with support from the literature with ways to reduce
barriers as they have been identified from pre-assessment surveys. The pre-education
phase of the project occurred over a 1-week period.
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Visit number two occurred 1 week after the pre-education visit and marked the
initiation of the education phase of the project. The medical director attended an
educational in-service in the clinic breakroom along with providers on hand for patient
care were given a copy of the urgency statement to use a guide over the next month in
their clinical practice. I delivered the educational content from the urgency statement to
the providers and the nurse champion in the centralized breakroom in the clinic. I
presented the findings from the presurvey and the current data on the HPV virus,
vaccines and barriers as they were identified on the survey in an open discussion format. I
used a poster as an aid to present the information that aligned with the vaccine from the
CDC as well during the discussion. The providers had an opportunity to ask questions
during and after the in-service. The providers and clinic nurse were able to reach me via
email if they had questions regarding vaccination recommendations or the material
presented in the in-service for a month after the education phase. The education phase
occurred over a 4-week period.
Visit number three occurred 5 weeks after the delivery of the urgency statement
and evidence-based guidelines. During the post education visit I returned to the clinic to
give the post education survey titled the “WD4019: You Are The Key to HPV Cancer
Prevention-2018” to the nurse champion who delivered it to the providers to complete in
the centralized nurses station. Providers completed the deidentified surveys and returned
them to the nurse champion who placed the surveys in an envelope titled “Post-Education
Survey” and returned them to me during my visit. The vaccination champion obtained the
vaccination recommendation report from the electronic record and provided the results to
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me during my visit in a separate envelope marked “Vaccination Recommendation
Report”. All the data were kept deidentified and secured in the private office of the nurse
champion. The data were transferred to an electronic spreadsheet that was password
protected and encrypted to examine the breakdown of which barriers were chosen.
Finally, the post education evaluation occurred 1 week after data were received from the
champion and entered on the spreadsheet. I analyzed the data from the presurvey and
postsurvey and the data on vaccination recommendation rates before and after education
to evaluate if the educational in-service closed the gap on the knowledge deficit and
reduced barriers to vaccination recommendations within the provider group. The total
project time was 6 weeks from preassessment to analysis of the results.
The purpose of this project was to demonstrate that primary providers had a direct
and positive influence on HPV vaccination recommendations and adherence. In-service
and urgency statement delivery reduced barriers and closed the knowledge gap for
providers responsible for HPV vaccination. Fisher-Borne et al. (2018) discussed how
Federally Qualified Health Centers are eligible for grant monies for efforts to increase
vaccination rates. Providers disseminate evidence-based practices by using collaboration
strategies in strategic program development to ensure high levels of participation and
demonstrate a positive return on investment to improve quality of care within the
provider population in any wellness related program such as vaccination (Palumbo,
Sikorski, & Liberty, 2013).
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Significance
The primary stakeholder was the primary provider who benefitted in the
education model for vaccination recommendation by supporting the Healthy People
initiatives and supporting healthy living by preventing disease in their patient
populations. The preteen patient and parents were the secondary stakeholders who
directly benefitted from an HPV provider education by experiencing better wellness and
health outcomes. Many socioeconomic and behavioral factors have impacted the
vaccination rates for HPV, but it is the consensus that involving clinicians, parents and
the adolescent patient as stakeholders in the discussion around vaccination will improve
adherence (Cole et al., 2017). Lollier et al. (2018) described how primary provider
knowledge and support is a common theme to vaccination adherence and disease
prevention. The four recommended vaccines for adolescents are tetanus, diphtheria,
toxoid/acellular pertussis (Tdap), meningitis, influenza, and HPV with adherence rates
between 80 and 90% for the first two (Lollier et al., 2018). The discrepancy between the
three commonly administered vaccinations and HPV vaccination is believed to be due to
health care provider barriers including limited knowledge, the stigma around sexual
activity discussion and young age, parental perceptions and lack of awareness (Cole et
al., 2017). Therefore, educating the providers on the facts of HPV vaccination, risks,
benefits and indications has in turn equipped them to have the same impact when
discussing the topic with patients and result in higher vaccination adherence. Because
HPV infections usually do not cause symptoms and transmission of the disease occurs
from sexual behaviors, the preteen and parent must rely on the provider to openly
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communicate about priority risk reduction (Cole et al., 2017). Therefore, the primary
provider is primarily responsible for addressing these barriers to recommending
vaccination and holds the most influence on outcomes (Niccolai et al., 2018).
Contribution of the DNP project can be accomplished by educating the providers
in multispecialty care using health promotion frameworks. As a DNP, I can provide an
urgent and informative delivery on the need for HPV vaccination and list facts related to
possible side effects. I can also provide ways to remove or overcome barriers in order to
open dialogue between patients, parents, and providers around risky sexual behavior and
cancer prevention through nursing science and education models. Many attitudes and
personal biases existed in the vaccination discussion, and educating using an evidencebased framework has demonstrated ways to limit bias in approaching the topic of
vaccination with eligible preteens and their parents.
By effectively using an applied theoretical framework in nursing, such as the
health promotion or health belief model, advanced practice nurses may in turn act as a
liaison between disciplines and show application to clinical practice as education
improves outcomes. The evidence justifies HPV vaccination as an imperative importance
to the nursing profession. Assessing behavioral factors in healthy and non-healthy
individuals is a key role for a professional nurse, as is the ability to help patients maintain
health through educational measures or framework. When assessing how behavioral
factors such as perceived risks and benefits to vaccination are relayed from provider to
patient, Pender’s HPM will provide the framework on which to base recommendations
for change. Education projects striving to increase vaccination recommendations may be
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transferred to other large-scale communicable disease prevention platforms. However,
advanced providers understand that HPV-related cancers continue at a staggering rate
because vaccination adherence remains less than 80% as recommended by the CDC
(Sussman et al., 2015). To significantly reduce infections and eliminate HPV-related
cancers, providers worldwide must remain advocates for their vulnerable patient
populations locally and globally through education, policy advocacy and by avoiding
personal bias and barriers to recommendation. Education frameworks can be used across
disciplines to make the kind of positive and measurable impacts to prevent disease in
nursing, medicine, social sciences, and beyond.
Vast positive social changes can be made to promote health as it relates to
sexually transmitted HPV and elimination of associated cervical and oral cancers locally
and globally. HPV infection is pandemic, and the intervention has the potential to make
positive impacts on our local, national, and even global communities (Fedewa et al.,
2018). Because HPV is a sexually transmitted infection, the healthcare provider focus
should be on education regarding cancer prevention to necessitate adherence. As an inservice-related staff education project, measured outcomes to improve patient care and
achieve standards of practice have become a part of the framework and program
objectives for this clinic and included identifying the programs’ impact on social change.
Summary
The CDC established the Healthy People 2020 initiative for HPV vaccination
uptake of 80% in effort to effectively eliminate HPV associated cancers. Both men and
women are being diagnosed with HPV-related cancers despite health care initiatives and
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provider awareness campaigns. The primary project goal is to increase HPV vaccination
recommendation rates for children aged 11-13 years by improving the vaccination
knowledge and recommendations to greater than 80% in the month post education.
Vaccination administration rates at the project site were reported at 3% over the last
quarter, believed to be due to many behavioral barriers. The practice-focused question
was, will educating the primary providers increase knowledge and recommendation rates
for preteen vaccination of HPV. The use of Pender’s HPM provided key elements of a
framework to determine perceived and actual barriers to vaccination and develop
strategies to overcome barriers to recommendations for HPV vaccination. The nature of
the project was focused on health promotion activity through vaccination
recommendation. Vaccination recommendation rates in the provider target population
were evaluated using Pender’s HPM assumptions around actual and perceived barriers.
Social impacts were made to positively promote health as it relates to sexually
transmitted HPV and elimination of associated cervical and oral cancers locally and
globally. Section 2 presents the background and context for the DNP project by
describing appropriate models and theory relevant to nursing practice and explaining the
role of the DNP student within the context of program implementation.
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Section 2: Background and Context
Introduction
The purpose of the project was to provide urgency-based education to
multispecialty providers in order to increase their knowledge on the current standard of
care for recommendations for HPV vaccination and identify and reduce barriers to HPV
vaccination in the preteen patient population. The problem question was, will educating
primary providers on the urgency and barriers to HPV vaccination increase HPV
vaccination recommendation rates for preteen patient populations. The following section
will discuss how Pender’s HPM is an appropriate theory to demonstrate support for HPV
vaccination recommendation and creating social change. Section 2 also identifies
relevance to nursing practice application, gives local background and context, and
elaborates on the role of the DNP student.
Concepts, Models, and Theories
The theory applied to the project is a middle range nursing theory that integrates
nursing and behavioral science concepts called the Pender’s HPM (McEwen & Wills,
2014). The HPM is an extension of the social cognitive theory, a grand theory evaluating
behaviors within social science. The HPM holds assumptions that largely evaluate
psychosocial behaviors of individuals and communities in order to engage them in
learning new behaviors that are geared toward health promotion, not just illness
avoidance (McEwen & Wills, 2014). Major concepts under the HPM include personal
experiences and bias (McEwen & Wills, 2014). Behavioral considerations are the major
underpinnings to the HPM. Behavior specific cognitions include perceived barriers and
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benefits to action, perceived self-efficacy, activity related effects, interpersonal and
situational influences (McEwen & Wills, 2014). Behavioral outcomes include the
commitment to a plan of action that may be impacted by a person’s preference and own
health promoting behaviors (McEwen & Wills, 2014).
The HPM supported my vaccination recommendation program specifically by
describing how vaccination recommendation enables the provider to encourage people
towards disease prevention and engages individuals to take care of their community.
Vaccines not only promote healthy behaviors, they also reduce rates for comorbid
conditions that follow in population families, schools, workplaces and larger
communities (Senkomago et al., 2017). Education on HPV also requires discussion on
other health promotion activities, such as safe sex practices and screening with cervical
exams (Senkomago et al., 2017). Individual provider behaviors and the culture within a
provider practice may also place unseen barriers on the ability for providers to
recommend the vaccine in eligible patients (Senkomago et al., 2017). By using the HPM,
the DNP prepared nurse may then have the means to identify actual and perceived
barriers of those providers responsible for recommending the vaccine. The practitioner
will then gain insight into how to reduce or eliminate barriers identified in the survey to
improve vaccination recommendation strategies. Nursing models in practice change
allow a catalyst for advanced practice nurses to demonstrate a cross discipline application
and close gaps in continuity of care (McEwen & Wills, 2014). While the providers in the
target practice population will not be provided education on the model directly, they may
have a general awareness of how barriers are perceived or otherwise can affect health
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promotion. Discussing barrier identification and allowing for anonymous replies in
surveys will reduce stigma, and possibly fear, as it relates to health promotion around
sexual behaviors in the patient. The project is asking the provider to reflect on personal
barriers to recommendation as well as the perceived barriers among the parent population
for the preteen. The survey used measured the perceived barriers to vaccination from the
provider viewpoint and does not reflect the opinions of the parents or the preteen
adolescent directly.
Relevance to Nursing Practice
HPV vaccination holds relevance in nursing practice as evident by the continued
incidence and prevalence of HPV infection despite social and political efforts. After more
than a decade of vaccination awareness, clinicians are continuing to record low rates of
vaccination adherence in practice (Niccolai et al., 2018). Recommendation to vaccinate
has been identified as the most significant predictor of vaccination adherence among the
pre-teen population (Niccolai et al., 2018).
Conducting a vaccination adherence project in a multidisciplinary clinic increases
the feasibility of vaccination, as primary clinics have certified family practice, internists,
and pediatrician providers (Niccolai et al., 2018). Clinics with specialty providers have an
inter collaborative approach and are increasingly likely to appoint vaccine champions,
use standardized policies and schedule appropriate time to visits scheduled for
vaccination (Lollier et al., 2018). Vaccination services are provided through a nurse
vaccination champion and office encounters. Considering age-appropriate demographics
for HPV, the clinic had a vaccination adherence rate of 3% per month in a quarter year,

16
which is well under the national average and the benchmark of 80% recommended by the
CDC (HPV Vaccines, 2019). Although there are ample providers in multispecialty group
treating preadolescent patients, poor vaccination adherence is a multifactorial problem.
Anti-vaccination protestors have strong emotional responses to risks related to vaccines
and providers may have knowledge gaps about the risk-benefit profile for HPV
vaccination specifically.
Perhaps the most significant measure for poor vaccination in the region is lack of
access. Lack of access in this region can be explained by the rural nature of surrounding
counties. The county health department reports that there are higher numbers of parents
reporting lack of access to care related to time and travel to care centers compared to anti
vaccination philosophies (Capps, 2019 para. 7).
The proposed project worked to fill in the gap to practice by using evidence-based
practice standards. The standards of care that increase knowledge on the current state of
HPV infection on the urgency statements during in-servicing were created from materials
obtained from the CDC. By increasing knowledge on the problem of HPV infection and
current standards to care for the provider, the project helped providers in turn become
increasingly able to address the barriers to vaccination for their patients. For example,
lack of access of care was identified as a significant barrier to vaccination
recommendation and adherence. Once the lack of access barrier was identified, the
provider referred to the urgency statement explaining to the adolescent that if they
adhered to the vaccine before age 15, the recommendation protocol would be reduced to
two injections from the standard three (Lollier, et al., 2018), thus, reducing trips to the

17
center for care and improving access. Advanced practice nurses are positioned to make
meaningful impacts in vaccination compliance by disseminating and translating research
on barriers to vaccine recommendation. The use of Pender’s HPM provided key elements
to evaluating for perceived and actual barriers to vaccination and develop strategies to
promote social change (McEwen & Wills, 2014).
Local Background and Context
Locally, the public commissioner of health and the CDC have reported that
although national HPV vaccination rates among eligible adolescent patients are recorded
at 40%, our state records an uptake of vaccination of only 30% (HPV Vaccines, 2018).
The problem of HPV infection is reaching 45% of the U.S. population and is anticipated
to grow if states do not react to find vaccination compliance strategies (HPV Vaccines,
2018). Because recommendation to vaccinate is considered the number one predictor to
vaccine acceptance, the vaccine initiatives have been a focus for providers and health
systems across the country. In my state, and specifically at the multidisciplinary clinic
where this project took place, vaccination recommendation rates have no monitoring
policy. Tdap and meningitis vaccination adherence has grown to greater than 80%
nationally as the initiatives for school-based admission programs have mandated
vaccinations (American Academy of Pediatrics, 2019). While vaccination mandates are
in place for Tdap, and meningitis, school systems across the United States have not
mandated HPV vaccines related to the barriers around the sexually explicit nature of
transmission (HPV Vaccines, 2018). In this region, barriers to recommendation include
lack of access related to the rural location of the community and low socioeconomic
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status that places adolescents at the threshold for poverty (Vaccines CDC, 2019). A
multispecialty clinic in the region was identified to be a direct representation of the
community’s at-risk population. The clinic employs 21 providers including pediatricians,
primary internists, nurse practitioners and physician assistants. A needs assessment
revealed that there was no tracking system for provider recommendations to vaccinate.
The vaccine adherence rate measured for the clinic in the preliminary assessment was
found to be 3%. The premise for the project was based on the CDC’s recommendation for
HPV vaccination adherence to reach 80% (Vaccines CDC, 2019).
The federal initiative for public health on HPV vaccination is called the Hub and
Spoke Initiative ( AAP, 2019). In a collaboration with the CDC and the AAP, the
Community Guide and the Hub and Spoke Initiative were formed. The priority of the
Hub and Spoke Initiative is to focus on creating peer-guided accountability on strong
provider recommendations for vaccination against HPV (AAP, 2019). The cultural,
ethical, and legal obligations to promote wellness through vaccination becomes
imperative in the framework of preventing the spread of HPV infection because
infections are directly related to higher risk for cancer (AAP, 2019). With any illness that
is spread through sexual transmission, a stigma and fear may be present, not just in the
parental community, but the provider one as well (Fedewa et al., 2018). The DNP project
is based on the Hub and Spoke initiative and legislation that focuses on prevention of
disease by placing focus on provider recommendation strategies and peer to peer
accountability (AAP, 2019).
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The NVAC supports administration of the HPV vaccine at the same time
meningococcal and Tdap vaccines are given, which is typically at 11 to 12 years of age
(Cole et al., 2017). Because pediatrician providers have shown higher rates of vaccine
administration awareness, the multispecialty provider clinic is an appropriate choice
(Cole et al., 2017). Tdap and MCV4 vaccines are administered nationally at or above the
80% benchmark, but do not include needed counseling or implementation strategies to
overcome behavioral barriers associated with HPV (Lollier, et al., 2018). While
pediatricians vaccinate at higher percentages compared to family practice providers, the
rates for HPV vaccines are higher for girls as compared to boys, providing additional
claim that screening in cervical cancer has increased the gap to vaccination between the
sexes (Lollier, et al., 2018).
Role of the DNP Student
As a DNP student completing a practicum in a related field of Oral and
Maxillofacial Surgery, I have a favorable referral base and a productive interdisciplinary
professional relationship for an HPV vaccination project. Due to the compressed
timeframe for data collection, I was unable to collect data for the full 6 to 12-month
vaccination open period for series completion. However, it was feasible to complete a
one-month post education data collection and monitor for increased vaccination
recommendation over five weeks. The pre assessment identified perceived behavioral
barriers to vaccination. The survey was adapted from current provider-based survey after
the literature review and titled “WD4019: You Are The Key to HPV Cancer Prevention-
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2018.” I provided paper copies of the pre surveys and reference list to the nurse champion
and she delivered them to the providers in the clinic.
I evaluated the data report, the results from the pre assessment survey and the
current literature from the CDC and current peer reviewed literature in order to develop
an urgency statement. The urgency statement was a one-page statistically significant
information sheet on the facts about HPV, vaccination risks and benefits and identify
ways to overcome barriers to vaccination. The urgency statement on HPV and
overcoming barriers was aligned with support from the literature with ways to reduce
barriers as they have been identified from pre assessment surveys. I presented the
findings from the pre survey and the current data on the HPV virus, vaccines and barriers
as they were identified on the survey in an open discussion format. I used a poster as an
aid to present the information that aligns with the vaccine from CDC as well during the
discussion. The providers had an opportunity to ask questions during and after the inservice. The providers and clinic nurse were able to reach me via email if they had
questions regarding vaccination recommendations or over material presented in the inservice for a month post education. I returned to the clinic to give the post survey titled
“WD4019: You Are The Key to HPV Cancer Prevention-2018” to the nurse champion at
which time she delivered it to the providers to complete in the centralized nurses station.
Providers completed the de identified surveys and gave them back to the nurse champion
to place in an envelope titled “Post Education Survey” and returned them to me during
my visit. Finally the post education evaluation occurred over one week, this is when I
assimilated the data from the pre and post survey’s and the data on vaccination
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recommendation rates pre and post education to evaluate for whether the educational in
service closes the gap on the knowledge deficit and reduces barriers to vaccination within
the provider group.
My personal motivation for developing a project in the area of HPV vaccination
was based on personal experience. As a nursing student in college I recognized a friend
had a hard non movable “lump” along the cervical chain. The lump was misdiagnosed
initially, but ultimately was found to be a malignant squamous cell filled lymph node.
The etiology for the node was deemed likely to be related to a high-risk form of HPV. I
feel a moral obligation to apply scientific knowledge and assessment of the infection,
transmission, prevention strategies, and ways to overcome barriers where it will make the
most positive impact and compel social change. As an advanced practice nurse, I am
aware of the responsibility to prevent HPV infection in pre-teens and sexually active
adults alike. HPV may also lie dormant and cause cancers to develop years or even
decades after exposure (HPV Vaccines, 2018). As I grow to understand barriers to
vaccination inside each target population, I have learned that the healthcare provider
recommendation makes the most impact toward adherence (Lollier, Rodriquez, SaadHarfouche, Widman, & Mahoney, 2018).
Oropharyngeal, cervical, anal, penile, and vaginal cancers are all continuing to
occur in the United States despite awareness of the disease (Vaccines CDC, 2019).
Cervical cancers have trended downward over the last fifteen years but may be related to
increased screening along with vaccination in girls (Lollier, Rodriquez, Saad-Harfouche,
Widman, & Mahoney, 2018). There are currently no screening recommendations that
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have been shown meaningful for other types of cancers in women or men (Lollier, et al.,
2018). Barriers to vaccination are linked to demographics and socioeconomics (Cole et
al., 2017). Communities should be educated on cancer prevention as a priority with HPV
vaccination. The healthcare provider should stay up to date on current trends and speak
knowledgably on cancer prevention. No person should suffer the consequences of a
preventable cancer or related treatment, including surgical complications, swallowing
difficulty, depression, pain, infertility, or any of the countless other potential life
changing effects from chemo and radiation therapies (Coley, Hoefer, & Rausch-Phung,
2018).
Personal bias may exist related to the underlying passion I have for vaccination as
a healthcare provider. I will address the bias by evaluating individual provider barriers
without giving a personal context of accounts. It is my goal to identify provider barriers
and use scientific knowledge from the literature to define ways to educate providers on
ways to overcome their perceived or actual barriers without relation to anything outside
of the research. By using the CDC education statements and modules on HPV vaccines I
can avoid personal bias or interpretation.
Role of the Project Team
The project team consists of a medical director, nurse champion and the DNP
student. The medical director had complete oversight of the process of data collection for
the practice site and worked with the DNP student to liaison between the nurse champion
and providers. The nurse champion works as a representative of the medical director and
providers at the practice site. The nurse champion collected and stored all deidentified
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data regarding HPV vaccination rates and delivered those to the DNP student prior to and
post the education in-service visit. The nurse champion directed the DNP student to the
nurse commons on the day of the urgency statement delivery and in-service.
Summary
By using theory and nursing health promotion models to build a provider
education program I am positioned to make large social impacts in the area of HPV
vaccination recommendation. Actual and perceived barriers to treatment have been
shown to exist in the provider and patient groups within the context of vaccination
outside of HPV. The same measures that are used in the CDC frameworks can be easily
applied to the DNP project on vaccination. Because inter collaboration is an imperative
part of research translation for practice, the DNP prepared nurse’s role in any vaccination
project is to ensure that all identified gaps in care delivery are recognized and that
barriers are reduced or eliminated. Empirical knowledge in nursing has proven to be a
motivating factor for many advanced practitioners looking to make change. By recalling
life events and applying evidenced based practices to experience allows for a deeper
impact to be made. Personal bias in project programs can be eliminated if the DNP uses
research to close gaps and keep dialogue open between healthcare disciplines.
Section 3 discusses the collection method and study design as it relates to the
problem focused research question. The research question of the DNP project asks how
improving knowledge on HPV may improve provider recognition of barriers and
recommendation for vaccination in the pre-teen adolescent. The section also provides an
analysis and synthesis of the evidence as it relates to the project question.

24
Section 3: Collection and Analysis of Evidence
Introduction
Evidence of a global pandemic has resulted in the CDC recommending HPV
vaccination penetrance of 80% in the population as part of the Healthy People 2020
Initiative, but efforts have proved futile as actual vaccination rates remain closer to 57%
in the United States (Sussman et al., 2015). While researchers evaluate why vaccination
adherence remains low, there is growing concern about HPV-related cancers. There is
significance in HPV vaccination as a public health problem because, after more than a
decade of HPV vaccination awareness, providers are still not meeting the
recommendations to vaccinate (Niccolai et al., 2018). Because recommendation to
vaccinate is considered the number one predictor to vaccine acceptance, the vaccine
initiatives have been a focus for providers and health systems across the country.
In my state, and specifically at the multidisciplinary clinic where this project took
place, vaccination recommendation rates have no monitoring policy. The context of HPV
vaccine recommendation is supported by evaluation of the barriers. Barriers including
cultural, ethical, and legal obligations to promote wellness through vaccination become
imperative in the framework of preventing the spread of HPV infection, because
infections are directly related to higher risk for cancer (AAP, 2019). Many public health
initiatives have been formed that support education frameworks and peer-guided
oversight that may prove effective in strategy development for HPV vaccination such as
the Hub and Spoke Initiative. Section 3 will present the practice-focused question, the
sources of evidence, analysis and synthesis, and summary of the DNP project.

25
Practice-Focused Question
Because HPV is a sexually transmitted infection, the healthcare provider focus
should be on education regarding cancer prevention to necessitate adherence. Low
vaccination administration rates at the project site, reported at 3% over the last quarter,
are believed to be due to many behavioral factors. By educating the providers in the
multispecialty clinic, I provided an urgent and informative state of the need for HPV
vaccination and listed facts related to possible side effects. Many attitudes and personal
biases exist in the vaccination discussion, and educating providers using an evidencebased framework demonstrated ways to limit bias in approaching the topic of vaccination
with eligible preteens and their parents. Therefore, educating the providers on the facts of
HPV vaccination, risks, benefits, and indications has in turn equipped them to have the
same impact when discussing the topic with patients and result in higher vaccination
recommendation rates.
The practice-focused question for the DNP project was, will education of primary
providers increase knowledge and recommendation rates for pre-teen vaccination of HPV
at a multidisciplinary clinic? By surveying the providers within the practice group, the
advanced practice nurse identified perceived barriers to vaccine recommendation. The
barriers identified within the presurvey were guided by Pender’s HPM. The rates of HPV
recommendation were measured before and after the education in-service, and I observed
whether a correlation exists between education and recommendation rates in the provider
group for their preteen patients.
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DNP-prepared nurses are especially equipped to translate the research into
practice-related change. By searching appropriate peer-reviewed sources for defined and
approved frameworks, the advanced practice nurse drives quality in care delivery. I
identified the multispecialty site for the project because the large numbers of
multispecialty providers and eligible patients and the opportunity to apply the evidence
for recommendation during patient visits. A medical director provided oversight the
project and the nurse vaccination champion will deliver data on rates for vaccination
recommendation. I obtained and secured clinic data through the vaccination champion
and clinic visits occurred on three separate occasions over a period of 6 weeks.
Sources of Evidence
The search engines and databases used for an educational framework on
vaccination recommendation improvement project included CINAHL, MEDLINE,
ProQuest, and OVID Nursing Journal review. Search terms included HPV vaccination,
adherence, vaccination surveys, education, primary provider, advanced practice nurse,
nursing model and theories, health promotion, advocacy, lack of access, and
immunization barriers. I conducted the literature search in 2019 with inclusion factors of
articles published in peer-reviewed academic journals from 2014 through 2019. Boolean
operators were AND provider education OR immunization barriers under the topic title of
HPV vaccination recommendation. Exclusion criteria were publications from books or
articles focused on vaccination in general terms outside of HPV. Articles written outside
of the English language were also excluded. A total of 417 articles were located and 35
were used after a completion of a literature review matrix (see Appendix B).
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Cole et al. (2017) assessed barriers to HPV vaccination and developed strategies
to overcome them through education using the HPM. Using a mixed methodology
interviews, surveys, and teaching points within the provider, patient, and parent
population, the researchers measured a response to vaccination as a preventative measure
and directly measured the effects of vaccination strategies on HPV infection rates (Cole
et al., 2017). Results showed improved vaccination rates among centers with developed
education methods for delivery of care (Cole et al., 2017). Evidence demonstrated that
continued studies were needed to identify the cost effectiveness of using interviews and
surveys as tools compared to treating HPV infection (Cole et al., 2017). The study is
directly aligned with the DNP project study as it provides a framework for continuation
in assessing how education impacts the rate at which HPV vaccination is being
recommended among eligible patients.
Senkomago et al. (2017) performed a worldwide evaluation of HPV vaccination
strategies and surveillance of screening methods as it relates to preventing HPV-related
cancers. The researchers wanted to have a global lens into the problem of HPV and
enlisted the help of the WHO and the Pan American Health Organization (PAHO) to
provide recommendations on vaccination and screening. The role of nurse was noted as
synonymous with caring and education around the world in areas of cervical cancer
screening. Placing the nursing professionals at the forefront of education made them a
crucial part of the Workforce Development team to help address disparities in cancer
related HPV prevention strategies. Despite rural and low-income countries having lack of
access barriers, the Global Initiative for Cancer Registry Development has a goal to reach
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150 countries participating in advocacy and collaboration networks. HPV has been
identified as the cause for nearly all cervical cancers, some of the vaginal cancers and
most oropharyngeal cancers around the world (Senkomago et al., 2017). As HPV
infection and related cancers are continuing to climb, global initiatives for surveillance
and vaccination are becoming a priority (Senkomago et al., 2017). The DNP project is
supported by the article because it demonstrates the need for education on vaccination
through inter collaboration and advocacy efforts described in the project.
A systematic review article on policy changes in vaccination may be the most
imperative strategy against the barriers of lack of access, parental social concerns, and
bias within providers during vaccination visits (Haddad, Allen, Szkwarko, Forcier, &
Paquette, 2018). Policy changes may support reducing or eliminating parental consent for
vaccination, such as in Title X Authority, which enables teens to obtain oral
contraceptives without parental consent, and would also promote school system
involvement in vaccine administration at schools to be all inclusive of Tdap, flu,
meningitis (Haddad et al., 2018). Concerns from parents such as “My daughter is too
young to need the vaccine” or “The vaccine promotes early promiscuity” are addressed
through policy support within the Title X Authority that reports it recognizes the
“importance of confidential and preventative reproductive health to all adolescents”
(Haddad et al., 2018, p. 13). The DNP project evaluates for barriers within the provider
population and is supported by the article because the researchers describe how barriers
to recommendation may be overcome if providers focus discussion around cancer
prevention rather than sexual transmission and activity.
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A mixed methods study evaluated the 15-year trends of cervical and
oropharyngeal cancer, finding that as a result of screening and vaccine the cervical
cancers have declined, but oropharyngeal cancers have continued to rise (Sussman et al.,
2015). A clinician questionnaire was used to survey external factors and barriers that had
potential influence on vaccination adherence. Sociocultural behaviors, media and policy
were evaluated, and providers reported a variety of challenges to vaccination
recommendation. It was found that only 9% of eligible adolescents received complete
series to vaccination. Recommendations included a set of counseling strategies for
overcoming identified barriers to vaccination recommendation. Researchers found that
the results of this study were consistent with other recently published qualitative research
studies (Sussman et al., 2015). Clinicians who focused on cancer prevention rather than
sexual activity counseling had a stronger adherence to vaccination. The article supports
the DNP project efforts to encourage provider recommendation by reporting the scientific
state of urgency behind rising infection and related mortality. The project provides a
scientific and statistical education on the state of HPV to educate providers and translate
evidence to practice.
Niccolai et al. (2018) held structured interviews in 2015 with 32 clinicians using a
thematic approach to evaluate the social impacts and barriers to HPV vaccination
recommendation. It was found that a strong recommendation from a provider was highly
motivating for the parent and patient in terms of vaccination adherence. Many of the
providers surveyed reported a lack of urgency to recommendation. Emergent themes
were identified from the questions that were asked in the interview on whether the

30
vaccine should be a mandate to healthcare or school attendance. Answers demonstrated
that a lack of requirement status had an important influence on providers
recommendation. Clinicians reported “it was not required for school, but we recommend
it”, “if we could start with here’s the HPV vaccine. It’s required prior to ninth grade” and
“That type of policy would help us.” Because the DNP project is directly surveying the
provider population for barriers to recommendation for HPV vaccine this article serves as
a direct example of how emergent themes within social barriers exist. The mid-range
nursing theory in Pender’s Health Promotion Model was chosen as the projects
framework for relating perceived social barriers into a care model evaluation.
A mixed method study was performed with the goal of examining the parental
and health system barriers to HPV vaccination (St. Laurent et al., 2018). The two most
reported reasons from parents on withholding vaccination from children were lack of
knowledge and lack of recommendation from their provider. The health system barriers
most frequently reported were lack of access and cost for series of vaccine (St. Laurent et
al., 2018). St. Laurent et al. (2018) researchers explain how non personal barriers may
also hold a role in lack of recommendations for vaccines. The DNP project is evaluating
how barriers of all personal or non-personal factors influence behavior and the article
gives support to addressing lack of access and cost in its assessment on the urgency
statement.
Clinics with specialty providers have an inter collaborative approach and are
increasingly likely to appoint vaccine champions, use standardized policies and schedule
appropriate time to visits scheduled for vaccination (Lollier, et al., 2018). Evidence
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supports a systems-process-outcomes evaluation because HPV is not a reportable disease.
The CDC has an approved self-survey module for providers that has 5 questions on the
epidemiology of HPV that will examine the providers’ knowledge base of HPV and
vaccination data that follows the CDC recommendation (Vaccines CDC, 2019). While
the eligible age for HPV vaccine is 9-45 years, the CDC recommends that a two series
vaccine be given at least 6 months apart to 11 and 12-year-old children. Data shows that
two series vaccine protects best if received before age 15 or before sexual activity has
started (CDC, 2019). Scientific data on the current state of national and global infection
rates supports the translation for the DNP project. The urgency statement will be created
from the most current data. The article provides scientific terms of when to deliver a
vaccine recommendation and sets the evidence-based care template for which the
providers in the project will make recommendations.
The American Cancer Society addresses the problem of poor provider vaccination
rates/recommendations by working as a direct partner in health initiatives and program
development in collaboration with CDC. A new set of initiatives have been created and
approved with new goals for vaccination of HPV focusing on reaching 80% adherence by
2026 (Fedewa et al., 2018). The HPM considers how behavioral factors within the
provider population affects whether the provider makes the recommendation to vaccinate.
Providers may have their own personal beliefs or opinions that present as barriers to
recommendation for HPV vaccine. Pender’s HPM applies theory to address the
disparities in health between males and females in receiving HPV vaccination. Lack of
access to care is a barrier that plays an environmental impact depending on geographic
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area lived when it comes to continued exposure to HPV and level of recommendation
(Healthy People, 2020). The overarching theme for the DNP revolves around evaluation
of how education may improve recommendation rates for HPV vaccination. With the
national guidelines remaining consistent in encouraging providers to overcome barriers to
reach 80% adherence, the article gives support to the project framework.
Evidence Generated for the Project
Participants
The participants within the multispecialty clinic have certifications in family
practice, internal medicine and pediatrics. There are 21 providers in the clinic composed
of seven nurse practitioners, eight physicians’ assistants and six medical doctors. The
clinic also benefits from the service of a full-time nursing care directive that encompasses
10 nurses and 1 nurse champion for vaccines. The providers maintain certification
through their respective certifying agencies and are in good standing under the licensing
boards. The practice is located centrally within the large rural community and serves as a
referring health system to over 12 major hospitals in the area. The practice area is in a
community in the Mid-Atlantic United States serving over 465,000 people within a 60
miles radius with an estimated 69,750 of those individuals being aged 6-18 years (Census
Bureau, 2018). The clinic identifies itself as a multifaceted Christian based affiliate for
healthcare.
Procedures
The medical director provided oversight in the process in which the nurse
champion will provide vaccination data on how many vaccination deliveries occurred
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from participating providers in the month prior to my initial visit for pre-assessment. The
champion had access to an electronic data base in which she obtained data specific to
HPV vaccinations in children ages 11-15 years old and provided the information as
deidentified data. The nurse champion created and then printed the deidentified
worksheet for me when I arrived.
The pre-education survey titled “WD4019: You Are The Key to HPV Cancer
Prevention-2018” is a brief assessment tool that includes 5 multiple choice questions
adapted from the CDC’s online CE module that will take approximately 5 minutes to
complete (see Appendix A). The questions evaluate the providers’ knowledge base on the
current statistics of HPV infection and evaluates behavioral barriers that discern
perceived or actual barriers to recommendation for the vaccine. The vaccination
champion delivered the survey to the providers while they work at the centralized nursing
station. The providers completed the paper and pencil survey between patient
evaluations. Providers consented to participate in the project with the completion of the
anonymous survey. After the providers completed the survey, they gave it to the nurse
vaccine champion who placed it in the envelope labeled “Pre-Education Survey”. The
nurse champion placed the completed surveys in a locked file cabinet within her private
office.
I evaluated the data report provided by the nurse champion to compare the
recommendation rate at the clinic for the HPV vaccine and related adherence rates to that
of national CDC goal of 80% vaccine adherence. The results from the pre-education
survey were reviewed within the nurse champion’s office and kept secure in the locked

34
cabinet until project completion. The survey was used to identify specific barriers to
recommendation and matched with statistical information regarding the scientific state of
the HPV vaccine. For example, the providers answered that lack of recommendation
comes from parental fear about possible adverse reactions from the vaccine, I placed
information on the urgency statement that provides an evidence-based response to
adverse reaction rates with the vaccine. The use of the evidenced- based literature
provides support to each identified barrier.
To develop the urgency statement, a literature review was conducted using the
Boolean operators AND provider education OR immunization barriers under the topic
title of HPV vaccination recommendation. Inclusion criteria included articles with key
search terms on provider education, statistics on HPV infection and vaccination
recommendation strategies. The articles included provided support to the provider
education model used in the DNP project and be dated between the year 2014- 2019.
Exclusion criteria are articles that focus on vaccinations for other diseases that weren’t
HPV. Articles written in languages other than English were excluded. A literature review
matrix was created and used to evaluate the literature. The urgency statement was a onepage statistically significant information sheet on the facts about HPV infection,
vaccination risks and benefits to vaccination adherence. The urgency statement on HPV
was aligned with support from the literature with suggestions on how to increase rates of
vaccination recommendation. The medical director was identified as the practice
representative and was responsible for reviewing the in-service materials and the urgency
statement before delivery.
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Visit number two occurred 1 week after the pre assessment visit. The providers
working attended an educational in service in the clinic breakroom and were given a copy
of the urgency statement to use a guide over the next month in their clinical practice. The
educational content from the urgency statement was delivered to the providers and the
nurse champion in the centralized breakroom in the clinic. Using a poster, I presented the
findings from the pre survey and the current data on the HPV virus, vaccines and barriers
as they were identified on the survey in an open discussion format. The providers also
had an opportunity to ask questions during and after the in service. The providers were
able to reach me via email if they have questions regarding vaccination recommendations
or over material presented in the in-service for a month post education. The vaccine nurse
champion also had my contact information. The education phase occurred over a fourweek period.
Visit number three occurred 5 weeks after the delivery of the urgency statement.
During the post education visit I returned to the clinic to give the post education survey
titled “WD4019: You Are The Key to HPV Cancer Prevention-2018” to the nurse
champion who delivered it to the providers to complete in the centralized nurses station.
The providers completed the paper and pencil survey between patient evaluations.
Providers consented to participate in the post survey with the completion of the
anonymous survey. Providers completed the de identified surveys and returned them to
the nurse champion who placed the surveys in an envelope titled “Post-Education
Survey” and returned them to me during my visit. The results from the post education
survey were reviewed within the nurse champion’s office and kept secure in the locked
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cabinet until project completion. The vaccination champion pulled the vaccination
provider recommendation percentages from the electronic record database and printed the
report without patient protected information. The champion placed the report in a
separate envelope marked “Vaccination Recommendation Report”. All the data was kept
deidentified and secured in the private office of the nurse champion. Review of results
occurred inside the nurse champions office only. None of the data sheets, surveys or
vaccination reports were removed from the secured office at any time. The data was
transferred to an electronic spreadsheet that was password protected and encrypted to
examine the breakdown of which barriers were chosen and all paper documents were
shredded.
Instruments
The National Committee of Immunization and Research (NCIR) and the ACIP
have defined evidenced based guidelines for HPV vaccination that the CDC used to
create the module (Health and Human Services, 2019). The CDC has a wide scope
initiative for HPV vaccination and program that includes references and tools for
clinicians contained in the HPV Toolkit and has an assigned approved Office of
Management and Budget (OMB) # 0990-0379 expiration date 9/30/2020 (Health and
Human Services, 2019). The tool titled “WD4019: You Are The Key to HPV Cancer
Prevention-2018” included five major item sections of content that measures learning
objectives in the areas of HPV vaccine as cancer prevention, indications for the vaccines
in boys and girls, components of vaccine recommendations, relevant and compelling
information on the vaccine for parents, and disease prevention risks and strategies
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(Health and Human Services, 2019). The tool was reviewed by the ACIP and placed in
the Morbidity and Mortality Weekly Report in February 2019 (Vaccines CDC, 2019).
The tool was approved for Continuing Nursing Education credit by the American Nurses
Credentialing Committee in April 2018 (ANCC) (Vaccine Education, 2018). The U.S.
Department of Health and Human Services and the ACIP references the tool throughout
the research and literature on HPV vaccination (Vaccine Education, 2018). There is no
information listed regarding the instrument’s reliability.
Protections
The project protects participants with the completion of human protection training
completion, CITI certification and Walden IRB. Walden IRB form A was completed and
submitted to be kept on file through the university. Systems used for recording and
tracking data for the DNP project included data retrieval from the electronic record
medical obtained by the vaccination nurse. Anonymity to the partner site name and
location was maintained along with ethical standards for the DNP project. Consideration
of barriers to vaccination included behavioral factors, and Pender's Health Promotion
Model to consider individual experiences, perceived benefits, barriers, interpersonal
influences, competing preferences and activity related affects to assimilate and develop
an urgency statement will be used. Positive behavioral effects include early and
appropriate access to vaccination age, therefore promoting full vaccination with just two
injections instead of three, discussing cancer prevention and promoting health behaviors
in adolescents and opening a dialogue about other sexual health behaviors and pregnancy
prevention as well (Holman et al., 2014).
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Analysis/Synthesis
The nurse champion recorded only the numerical percentages of the vaccination
adherence rates at the clinic and kept the report stored securely in her office until I
arrived to compare those percentages to eligible office visits. Statistical methods for
evaluation included a t-test to compare the pre-education vaccination recommendation
rates with the post education vaccination recommendation rates. However, the use of a
correlation coefficient was not used to measure strength and direction between provider
perceived barriers and recommendation rates as they independent variable of the study
were not constant.
Analyzing and maintaining deidentified statistics was done on a Microsoft Excel
spreadsheet. By using descriptive statistics to summarize the data placed in the
spreadsheet I was able to measure whether the staff education model had meaningful
impacts toward vaccination recommendation. Each answer chosen was counted and
totaled on the spreadsheet. Answers from the pre assessment survey were used to
calculate a total number of times it was chosen out of the total surveys received. The data
from the vaccination recommendation reports and the pre-education surveys helped to
define what urgency statement statistics were placed into the final urgency statement to
be delivered during the in service.
The practice focus problem of poor vaccination recommendation was evaluated to
discern if education through an in-service on the urgency of HPV vaccine improved
vaccination rates. After the in-service, the results were reviewed to count how many
times a survey answer was chosen. The pre survey and post survey responses were not
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evaluated by a correlation coefficient to determine how barriers chosen compared with
provider vaccination recommendation rates.
The evidence justifies HPV vaccination as an imperative importance to the
nursing profession (Vaccines CDC, 2019). Assessing behavioral factors in healthy and
non-healthy individuals is a key role for a professional nurse, as is the ability to help
patients maintain health through educational measures or framework. When assessing
how behavioral factors such as perceived risks and benefits to vaccination are relayed
from provider to patient, Pender’s Health Promotion Model provided the framework in
which to base recommendations for change. As an in-service related staff education
project, measured outcomes to improve patient care and achieve standards of practice
was a part of the framework and program objectives for this clinic and will include
identifying the programs’ impact on social change. In order to analyze or assess quality in
healthcare outcomes advanced practitioners consider the terms of restoring function and
survival within the target group (Donabedian, 2005). The Donabedian Model is a threepronged assessment in which the limitations must be described in relation to measured
outcomes.
Summary
The purpose of this project was to demonstrate that primary providers have a
direct and positive influence on HPV vaccination adherence through recommendation.
In-service and urgency statement delivery reduced barriers and close the knowledge gap
for providers responsible for HPV vaccination. Because HPV is a sexually transmitted
infection, the healthcare provider focus should be on education regarding cancer
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prevention to necessitate adherence. Vaccination administration rates at the project site
initially reported were 3% and were believed to be due to many behavioral factors. The
practice-focused question for the DNP project was, will education of primary providers
increase knowledge and recommendation rates for pre-teen vaccination of HPV at a
multidisciplinary clinic? By surveying the providers within the practice group, I
anticipated identifying perceived barriers to vaccine recommendation. The rates of HPV
recommendation were measured before and after the education in-service and I observed
whether a correlation was appreciated between barriers and recommendation rates in the
provider group for their pre-teen patients. The search engines and databases used for an
educational framework on vaccination recommendation improvement project included
CINAHL, MEDLINE, ProQuest, and OVID Nursing Journal review. 417 articles were
located and 35 were used after a completion of a literature review. The literature review
matrix was developed using the 8 major articles that supported the DNP project evidence
on education toward vaccination. The project was carried out over a 6-week timeline and
included oversight and approval from the practice medical director. Protections were
made to ensure ethical standards and privacy by de identifying all three instruments in the
project and the clinical site itself. Data was reviewed on site in the nurse champions
private office space. All surveys and data collected were placed in an envelope and
secured in a locked cabinet within the nurse champions private office. A statistical
analysis with t-test comparisons between pre and post education groups was evaluated as
well as the overall rate for HPV vaccination recommendation among the provider group.
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Section 4 of the proposal discusses the findings and conclusions of the DNP project and
reflects on the strengths and limitations of the project as it was implemented.
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Section 4: Findings and Recommendations
Introduction
The CDC established the Healthy People 2020 initiative for HPV vaccination
uptake of 80% in effort to effectively eliminate HPV-associated cancers (Vaccines CDC,
2019). Both men and women are being diagnosed with HPV-related cancers despite
health care initiatives and provider awareness campaigns. Locally, the public
commissioner of health and the CDC have reported that while national HPV vaccination
rates among eligible adolescent patients are recorded at 40%, our state records an even
lower vaccination uptake of 30% (HPV Vaccines, 2018). The problem of HPV infection
is reaching 45% of the U.S. population and is anticipated to grow if states do not react to
find vaccination compliance strategies (HPV Vaccines, 2018). Because the local region
had demonstrated poor vaccination recommendation rates, the problem focus within the
project was on assessing barriers to recommendations for prescribing the HPV
vaccination within the primary provider population.
Conducting a vaccination adherence project in a multidisciplinary clinic increased
the feasibility of vaccination, as these clinics have certified family practice, internists,
and pediatrician providers. The gaps in practice have been confirmed through the PreEducation Survey titled the “WD4019: You Are The Key to HPV Cancer Prevention2018.” Any decrease in vaccination adherence has a direct and inverse effect on increased
risk for transmission of the disease (Capps, 2019). The practice-focused question for the
identified problem of poor HPV vaccination rates was, will educating primary providers
in a multidisciplinary clinic on the current state of HPV result in increasing HPV
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vaccination knowledge and recommendations for vaccination of eligible pre-teens to
80%? The objective was to determine if education of primary providers would increase
knowledge and recommendation rates for preteen vaccination of HPV. Section 4 presents
the findings, implications, project team contributions and limitations that were made
evident as a part of this quality improvement project.
Findings and Implications
The purpose of this quality improvement project was to provide multispecialty
providers an evidenced based educational urgency statement on the current state of HPV
infection and complete an assessment of barriers related to recommendation to
vaccination in clinical practice. The framework of Pender’s HPM was compelling toward
creating evidence-based change as the framework promotes self-evaluation of perceived
and actual barriers in health. The DNP project began with an assessment of how one
multispecialty practice may improve their recommendation toward HPV vaccination after
an education in-service and an urgency statement on HPV facts. The clinic has 21
multispecialty providers, including internal and family medicine physicians,
pediatricians, nurse practitioners and physician assistants. The project included a review
of the current HPV vaccination recommendation rate at the site and a pre-education
survey that assessed the barriers to recommendation among the provider group. I
developed the urgency statement for education in poster format for the in service after the
data from the vaccination report and pre survey was evaluated. The urgency statement
was developed by using the literature review matrix and the CE Module from the CDC
(Vaccine Education, 2018).
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Pre-Education Collection of Vaccination Data
Retrospective data from the electronic medical record (EMR) were collected by
the vaccine champion for the month prior to project initiation to determine how many of
the in-office adolescent visits resulted in provider recommendation of vaccination for
HPV. The nurse champion provided the Pre-Vaccination Data Report to me for review in
her office after she created a report by identifying the meaningful use checkboxes for
HPV discussion in the electronic record. The providers would document their discussions
on HPV vaccination with patients and parents by using the check box system. The nurse
champion entered the key term “HPV” into the EMR to obtain the report for the 4-week
period prior to the in-service. The report revealed that there were 808 adolescent visits of
which 28 showed HPV vaccination recommendation through the checkbox system. The
baseline vaccination recommendation rate for the clinic during in office visits was 3%
(see Figure 1). Figure 1 shows the number of visits and recommendation rates for HPV
eligible teens from the month prior to the project start date. The total recommendation
rate did not consider the vaccine clinic visits if they were not associated with an in-office
visit. The clinical site operates an independent vaccine clinic that does not track
documentation check boxes on recommendations therefore the vaccine clinic visits were
not included in reported vaccination data.
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HPV Vaccination Recommendation Rates

3%

Adolescent visits
Adolescents receiving
recommendation
97%

Figure 1. Multispecialty clinic visits and recorded adolescent visits with recommendation
towards HPV at baseline.
As the DNP team leader, I transferred all data from the vaccination data report
into a password-protected Excel spreadsheet. The baseline data report represents the total
number of in-office visits, eligible teen visits, and total number of recommendations for
HPV for the clinic over the 4 calendar weeks prior to the initiation of the project (see
Table 1). The total number of monthly in-office visits for the clinic was 1,816 of which
the number of eligible teen visits were 808. Twenty-eight of the 808 teen visits had a
check box marked in the EMR representing a 3% recommendation rate for HPV
vaccination.
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Table 1
Number of In -Office Provider Recommendations for Eligible Adolescents at Baseline
Visit type

Patient visits (over 4 weeks)

Percentage

Monthly patients
Eligible teen visits

1,816
808

45

Visits with HPV vaccine
recommendation

28

3

Pre-Education Survey
Visit 1 occurred October 28, 2019 and marked the start of the project. The PreEducation Survey was distributed by the vaccine champion to the nine providers on staff
for patient care during that day. The vaccine champion placed the completed surveys in
the Pre-Education Survey envelope and filed the surveys in her locked, private office for
my review on site. The pre-education survey did not contain provider identifiers or
patient information in order to maintain security and prevent bias in interpretation.
The providers were administered a Pre-Education Survey on the potential barriers
to recommendation using a validated CDC tool and CE module titled” WD4019: You
Are the Key to HPV Cancer Prevention-2018” (see Appendix A). The survey responses
identified adverse reaction concerns and knowledge deficit as the largest barrier to
recommendation (see Figure 2). Barriers of parental “anti vax” philosophy, parental
consent, and religion were rated the same.
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Provider Barriers to HPV

Adverse Reaction
Concerns and Knowledge
Deficit
Anti Vax Philosophy

10%
10%
10%

Parental Consent
70%

Religion

Figure 2. Pre-education survey on provider barriers to recommendation.

I used the barriers of parental consent, anti-vax philosophy, and concerns about
adverse events to create the urgency statement as they were identified as the perceived
most common provider barriers on the Pre-Education Survey. Of the nine providers
present on visit 1, seven completed the pre-education survey. The barrier of religious
affiliation was not directly addressed on the urgency statement outside of simply
reporting that it may be cause for exemption within some parental groups.
Development of Education and the Urgency Statement
A literature review was conducted using the Boolean operators AND provider
education OR immunization barriers under the topic title of HPV vaccination
recommendation for the years 2014-2019. Inclusion criteria included articles with key
search terms related to provider education, statistics related to HPV infection and HPV
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vaccination recommendation strategies. The search engines and databases used to
develop the educational framework for the HPV vaccination recommendation
improvement project included CINAHL, MEDLINE, ProQuest, and OVID Nursing
Journal review. Exclusion criteria were articles that focused on vaccinations for diseases
other than HPV and written in languages other than English. Of the 417 articles that were
located, 35 were used as references for the project. The literature review matrix was
developed using eight articles that supported the DNP project evidence on education
toward vaccination. The eight articles included on the matrix were chosen specifically
because they reviewed existing education frameworks in schools or health centers
making them applicable evidenced based support references for the DNP project.
Knowledge gaps related to adverse reaction potential were also identified in the
provider group specifically regarding cancer occurrences related to HPV infection for
boys as compared to girls. The urgency statement was created by matching education key
points and objectives from the CE module from the CDC with the key findings on
adverse reactions from the literature review matrix (Appendix C). The five objectives on
the urgency statement aligned key concepts from the CE module from the CDC
including, understanding how the clinics adherence rate aligns with the CDC healthy
people 2026 goals on the indication for HPV vaccination in cancer prevention, explaining
how to implement disease prevention strategies, such as bundling school aged vaccine
recommendations, providing information to parents on the indications and safety profile
on HPV vaccine, providing knowledge that HPV causes cancers in girls and boys
including cervical, oropharyngeal, vaginal, penile, and anal cancers, and lastly explaining
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components of effective recommendation and timing to vaccination (Vaccine Education,
2018).
Education Framework
Visit two occurred on November 4, 2019 during the second week of the project.
At this time, the urgency statement was delivered in poster format. The poster was
displayed in the general provider break space and I was available for questions. The
medical director requested that there not be formal stop care meeting or in-service. The
providers would independently come by the break room and review the poster as they
were able on any workdays over the next four weeks. Because the providers on staff had
limited time to spend with me during the in service and urgency statement delivery the
medical director met with individual providers to give a review of the urgency statement.
I was unable to ensure the information was delivered to each provider with a serious tone
and sense of urgency due to the limited time and exposure I had with individual
providers. The program design was that I would hold a brief conference collectively for
providers on the second visit, which I was not given the opportunity to do. However, the
gaps identified in visit one on the Pre-Education Survey were consistent with the gaps
found in the literature from projects done in similar educational design. Along with
barriers the providers surveyed on visit one also identified a gap in HPV cancer
knowledge, therefore, the information used in creation of the urgency statement was
appropriately aligned to close gaps and overcome bias. Suggestions for ways to address
the areas of weakness to recommendation were described on the urgency statement.
Providers would be left to review the urgency statement on their own accord during their
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working timeline. The medical director explained that only nine of the 21 providers were
on staff the day of project visit two, and because not all the providers employed at the
clinic would have opportunity to hear the in service and education on HPV, that he would
directly review the information with all of the providers. I provided a detailed in service
on the HPV urgency statement and poster to him as the overseer of the clinic site and the
vaccine champion placed the poster on the wall in the provider break room at that time.
Post Education Survey
After 4 weeks of project implementation, the third and final visit for the DNP
project was December 2, 2019. The Post Education Survey was delivered through the
nurse vaccine champion to the providers in the clinic providing in office visits that day. A
total of five providers worked in the clinic this day with only four completing surveys.
The four de identified surveys were collected by the vaccine champion and placed in the
secure envelope titled “Post Education Survey”. The vaccine champion provided the
surveys for my review in her private office. Upon review of the data from the surveys I
recorded that three out four providers (75%) identified that adverse reactions from HPV
vaccine and the knowledge regarding how to handle those questions was the largest
barrier to recommendation (Figure 4). Concern regarding adverse reactions was the
largest perceived barrier in the Pre-Education Survey responses as well. The anti vax
philosophy was the only other perceived barrier for the post education group of providers,
with two out four (50%) reporting anti vax philosophy as a barrier to recommendation.
The pre-education barriers of parental consent and religion were not appreciated in the
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post education survey group. As the DNP project leader, I transferred all deidentified data
onto a spreadsheet on site before documents were shredded.
Provider Barriers to HPV Recommendation

40%
60%

Adverse Reactions and Knowledge Deficit

Anti Vax Philosophy

Figure 4. Post education survey on provider barriers to recommendation.
Post Education Collection of Vaccination Data
The Vaccination Data Report was printed by the nurse champion from the EMR
and kept secure in her locked, private office until my review. Once the providers
discussed HPV vaccination with the patient and parent, they were responsible for
checking the checkbox associated with in office education on HPV noting criteria was
met and project tracking was initiated. Over the four-week period from the date of
urgency poster delivery the total number of eligible visits and corresponding visits with
checkboxes marked were included in the report. The vaccination data report revealed a
100% vaccination recommendation rate for the post urgency in service time period (Table
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2). Table 2 represents the total number of in office clinic visits, eligible teen visits and
teen visits recorded with HPV recommendations for the four weeks since urgency
statement delivery at the clinical site. The total number of in office adolescent visits for
the post education month were 1,155. Of the 138 teen visits all 138 visits had recorded
recommendation toward HPV vaccination as evidenced by check box tracking. Because
this four-week time period was over a holiday week and less providers were seeing
patients, the total number of eligible patient visits were reduced compared to the baseline
data report.

Table 2
Number of In-Office Provider Recommendations for Eligible Adolescents During Post
Urgency In-Service Time Period
Visit type

Patient visits (over 4 weeks)

Percentage

Monthly
Eligible teen visits

1155
138

12

Visits with HPV vaccine
recommendation

138

100

The recommendation rates were collected for the month prior to project initiation
and then again collected during the one-month post urgency delivery for comparison
(Figure 3). The baseline total monthly visits for adolescents were recorded much higher
than the post urgency statement month. The discrepancy between recorded number of
office visits pre and post project was believed to be due to a modified holiday schedule in
November. Also, it is important to note the baseline month was a school start month and
the clinic schedules a high number of school start visits for physicals and vaccines as
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required by state and school health mandates. Recommendations to vaccinate have been
identified as the most significant predictor of vaccination adherence among the pre-teen
population, demonstrating how a provider focused project will create social change
(Niccolai et al., 2018).

Pre and Post QI Project Recommendation Rates

BASELINE RECOMMENDATIONS
POST URGENCY
RECOMMENDATIONS

808

138

Adolescent Visits

28

138

Recommendations

Figure 3. Multispecialty clinic recorded adolescent visits with recommendation toward
HPV in the pre and post urgency project period.
Summary of Findings
There was a statistically significant improvement in the rate of recommendation
for HPV vaccination after urgency statement delivery at the project site. The baseline
recommendation rate for the site was based on check box documentation on HPV and
was close to 3%. After education reassessment of the vaccination data for the four weeks
post education and urgency statement delivery recommendation was documented at
100% for the in-office clinic visits. The increase in monthly recommendation was 82
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additional recommendations or a 292% increase when comparing the post education time
period to the baseline rate. The project objective was to measure the rate of provider
recommendation toward the HPV vaccine for one month after urgency statement delivery
and show a quality improvement in practice.
Recommendations
Individual Stakeholders and Policy
Stakeholders for the DNP project included providers, parents, and adolescents.
Indirect stakeholders are the policy makers involved in creating solutions toward change
regarding vaccinations. While evidence toward HPV vaccination effectiveness is
deliberately sent to the public through media and trusted healthcare journals, providers
continue to demonstrate barriers to recommendation of HPV vaccine. Ways to address
the lack of access, associated costs of vaccination adherence and knowledge gaps on the
topic of HPV are delivered to the mainstream public but do not always create buy in.
With the anti vax movement in America and continued increase in rates of HPV-related
cancers, it is imperative that policy makers get involved in legislation toward change.
Healthcare policies work to allow for a concerted equal effort between state and federal
agencies to promote safety and quality while managing the cost to afford achieving and
maintaining of the vaccination adherence goal (France, 2008). The problem with the idea
of federalism is the cost structure. While federal support is gained through CMS at a
higher rate than what is expected of states, the idea of weighted control doesn’t always
fall into the hands of the federal entity. States are still very much in a fight to control
decisions that are often deliberated on by the federal government when they individually
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feel a loss of sovereign right to oppose any such policy (France, 2008). For example, the
Patient Accountability Act was implemented with a fee if individuals chose to forego the
purchase of health care, but states were quick to refute the fee and the demand for
coverage (France, 2008). Current policy funding for vaccinations is supported by the
CMS at a rate of 65% from federal sources and the remaining needs for cost coverage
must be met by state taxpayers (France, 2008). Proposals have been made to increase the
federal support from 65% to 72% but does not consider more control in decisions to
practice (Medicare and Medicaid, 2015). To specifically appeal stakeholders to cost
effective strategies, policies on HPV vaccination aim to consider as many state
representatives as possible, I have met with my state senators and representatives to
collaborate on solutions. The priority solution purposed is one that is feasible and
measurable focusing on the creation of state legislation that supports the addition of HPV
vaccination recommendation on physical examination forms for middle school aged kids.
By implementing verbiage on recommendation into tracking EMR systems for providers,
legislative measures may also encourage documentation of discussions with adolescents
and parents. Other considerations include removing parental consent, implementing
school programs or mandates, tightening vaccine exemption language, and expanding
federal initiatives, such as Title X Authority, for adolescents (Orenstein & Yang, 2015).
While the purposed solutions have potential to impact vaccination adherence, there is no
one solution to creating buy in among stakeholders. The largest impetus remains
education. The DNP project site currently uses physical forms that have been approved
for reprinting and education from the American Academy of Family Physicians, The
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American Academy of Pediatrics, the American College of Sports Medicine and the
American Osteopathic Academy of Sports Medicine 2010 version #CI-191D (5/12).
While the physical examination forms do not currently include any recommendation
toward age appropriate vaccines, State Senator Dr. Richard Briggs proposes to add HPV
vaccination recommendation to the physical examination forms. Other stakeholders to
consider in policy advancement toward HPV vaccination recommendation would be the
school board directors and the states medical association president for support.
Leading the way for advanced nurses, the American Nurses Association (ANA) is
also a prominent leader in community health and advocacy. The ANA has endorsed the
recommendation from the Expert Panel of Emerging Infectious Disease on the
recommendation for the use of vaccines for disease prevention (American Academy of
Nursing, 2014). CE nursing modules toward education on vaccine awareness and disease
prevention are available for clinician nurses from the ANA in efforts to support up to date
standards of care (American Academy of Nursing, 2014). Most recently the ANA
released a statement of support toward the CDC’s screening and treatment of Hepatitis C
and is offering education for nurses and advanced providers on up to date treatment
recommendations on both HCV and HPV (American Academy of Nursing, 2014).
Because my state of practice remains a restricted practice state (T.C.A.63-7) and has
made little advancement toward change in practice laws for advanced nurses in the last
fifteen years, scope of practice legislation may become a secondary policy issue related to
the project advancement that I pursue into my career (American Academy of Nurse
Practitioners, 2019). The position statement from the American Academy of Nursing
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2014 on the issue of infectious diseases and vaccination states “nurses should engage
local, state and national leaders through advocacy and education” thereby increasing
“awareness and access” within the communities they serve (p.372).
Clinical Sites and Change
The project site property has the potential to reach many eligible adolescents and
their parents if providers would consider adding a vaccination education model to their
walk-in and vaccine clinic. Currently the clinic does not have a formal way to track
eligibility outside of age and the checkbox system. A check box system is not
incorporated in the walk in or vaccine clinic that operates in conjunction with the main
clinic. The walk-in clinic feels a duty to provide timely urgent and sick care evaluation to
the community and does not place priority for HPV vaccination inside either of the
ancillary clinics. However, with the numbers of potential adolescent visits occurring in
the clinic it may be something to consider. Perhaps having a flyer on HPV to distribute at
these visits would allow the parent to consider the vaccine on the next visit or schedule a
visit in the vaccine clinic later. The vaccine clinic was not included in our project
outcomes because the clinic lacked the ability to track education on HPV or
recommendation. Currently the vaccine nurse can give vaccinations to those patients who
call in independently for vaccination. Adding a tracking box and an educational flyer for
both the walk in and vaccine clinic may also help the clinics move toward better
vaccination adherence. Increasing services to more outreach and ancillary clinics may
help to reduce lack of access to care and cost barriers by eliminating the socioeconomic
or demographic evaluation of the adolescents only coming to routine office visits for
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care. Feiring et al. (2015) explained how an association between parental income level
and adherence to HPV vaccination is often noted indicating that higher income parents
are more likely to have their child vaccination. In considering socioeconomic standing
the provider should also consider health literacy of the parents. As an inference to income
is often made by providers that connects income to education a careful health literacy
review should be considered in educational intervention programs for vaccinations as
health literacy and education do not always result in compliance of vaccination
recommendation (Feiring et al., 2015). By placing the health professionals at the
forefront of education, they became a crucial part of the workforce development team to
help address disparities in cancer related HPV prevention strategies. Despite rural and
low-income countries having lack of access barriers the Global Initiative for Cancer
Registry Development has a goal to reach 150 countries participating in advocacy and
collaboration networks. HPV has been identified as the cause for nearly all cervical
cancers, some of the vaginal cancers and most oropharyngeal cancers around the world
(Senkomago et al., 2017). As HPV infection and related cancers are continuing to climb,
global initiatives for surveillance and vaccination are becoming a priority (Senkomago et
al., 2017).
Support for Additional Clinics
While CMS and private payers are providing financial coverage at 65% of billable
services, the federal government also focuses on evidenced based practices that reduce
variation and are valid to translation in patient centered areas despite demographics
(Medicare and Medicaid, 2015). Since larger financial support is delivered from the
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federal government perhaps more control should be allotted therein and states should
follow suit. The focus of CMS based principles strive to reduce health disparities and
improve expansion of CMS services to all people, especially minority and vulnerable
populations (Medicare and Medicaid, 2015). Federal support is evident in healthcare
reform and is fostering changes we see in healthcare with the building of Accountable
Care Organizations, giving way to transformation of primary care, integration of
resources, payment reform, and developing strategies to measure quality (Medicare and
Medicaid, 2015). Multispecialty provider groups such as the one in the DNP project can
continue to work toward HPV vaccination recommendation long after the completion of
the project. Focusing on the Hub and Spoke Initiative from the ACS helps providers hold
each other accountable for recommendation. Reviewing the positions of other states in
the US reveals Iowa and Rhode Island are the two states that have unrestricted access for
adolescents under the Title X rule and have also been on the forefront of school-based
vaccination programs and sexual education frameworks. Ruger (2008) describes how
universal health care coverage is a crucial point to accessing high quality healthcare, as
insurance coverage lends itself to more resources for the care needed and is a major
economical barrier. Overall, increasing opportunities for multispecialty providers to
recommend and deliver the HPV vaccine will help move policy forward toward
improving adherence to vaccination but evidence suggests that providers would
recommend more often with the backing in school entry requirement, like those policies
that support Tdap and meningitis vaccines (Colgrove, Abiola, & Mellow, 2010).
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Local and Global Communities
The WHO has worked with countries on a grand scale toward HPV vaccination as
the infection relates to 14 million new cases a year in the US alone and 570,000
associated cancers (Altobelli, Rapacchietta, Profeta, & Fagnano, 2019). In the US we
may believe that vaccines are evidenced based but must also consider (by state) who is
going to fund such efforts (Eckenwiler, 2009). Barriers to vaccination in the US come in
many forms, such as lack of access or cost or stigma. Within the US constitution we are
presented a counterexample of perceived public health benefit and adherence (Colgrove,
Abiola, & Mello 2010). An example of counter belief comes from the 1905 Jacobson Bill
that describes how smallpox was eradicated. In 2006, the FDA approved Gardasil for
girls to prevent HPV-related infection and associated cancers, and then in 2011 the
recommendation for boys followed (HPV Vaccines, 2018). Healthcare leaders may
address barriers to recommendation by focusing legislation efforts on development of
vaccine policies or by incorporating stronger exemption language around several existing
vaccine policies. Currently there are school entry mandates around the Tdap and
meningitis vaccines that have resulted in adherence for vaccination to reach the 80%
benchmark across the US (Perkins, Lin, Wallington, & Hanchate, 2016). Because the
mandates have vague exemption terminology incorporated into them, parents can opt out
of vaccination leaving the unprotected students at risk for disease transmission (Haddad,
Allen, Szkwarko, Forcier, & Paquette, 2018). Language around existing mandates for
school entry could be added to include HPV as a precedent for change. The exemption
language could also be tightened to require religious clergy or medical exemption only,
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removing the parental exemption (Orenstein, & Yang, 2015). Lastly, considerations
toward writing expansion language around the federal Title X Authority to offset any
discrepancy around socioeconomic standing may also aid in higher adherence to
vaccination (France, 2008). The ACIP works with federal health agencies in developing
the evidence to support recommendation standards and EBP practices (Colgrove, Abiola,
& Mello 2010). After the FDA approved the use of the HPV vaccine for girls and boys,
42 states agreed to consider mandates for HPV vaccination, but only Virginia and the
District of Columbia ultimately adopted the mandate. Rates for adherence remained
57.3% in girls and 34.6% in boys compared to other mandated vaccine related adherence
rates with Tdap and meningitis of 91.3% (Orenstein, & Yang, 2014). The reason that,
despite mandates, adherence is believed to have remained low, is the issue of loose
verbiage around exemptions and individual rights (Perkins, Lin, Wallington, & Hanchate,
2016). Also, it should be noted that the current two states with mandates are only directed
to the female population in school-based programs resulting in continued low adherence
and support (Perkins, Lin, Wallington, & Hanchate, 2016).
The DNP prepared nurse specifically can work to increase knowledge among
multispecialty providers such as dentists, pediatricians, PCP, NP’s, to provide screening
and vaccine delivery. The DNP prepared nurse also should assist in developing state
policies and consider mandates for school entry-tightening exemption language by
becoming involved in policy (Tyer-Viola et al., 2009). Clinical practice in specialty areas
may benefit from an educational model that stresses urgency around HPV vaccination
and cancer prevention. The DNP nurse has a moral obligation to maintain HIPAA around
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vulnerable populations such as the adolescent. The DNP project addresses barriers to
access to care and improving vaccination adherence can be accomplished through
mandates or expansions in health programs. Maintaining HIPAA privacy laws and
promoting cancer prevention and risk behavior modification in vulnerable adolescent
populations continues to have ethical implications toward policy development.
Contribution of the Doctoral Project Team
The DNP project team consisted of myself, the medical director, and the nurse
vaccine champion. The medical director provided oversight and approval for all data
collection procedures and education delivery methods. The vaccine champion provided
data reports and served as a liaison between the providers and the project leader. The
Vaccination Data Report was printed by the nurse champion and placed in her private
office for my review. A vaccination data report was printed from the EMR using the
check boxes for HPV. The nurse champion collected and stored all deidentified data
regarding HPV vaccination rates and delivered those to me prior to and after the
education in-service visit. The nurse champion directed me to the nurse commons on the
day of the urgency statement delivery and in-service.
Over the four-week period from the date of urgency poster delivery the total
number of eligible visits and corresponding visits with checkboxes marked were included
in the report. The nurse champion also reported that she informed providers how she
would be tracking recommendation rates by using the meaningful use checkboxes in her
report as part of this project. The vaccine champion noted that flu vaccine administration
is up during winter months in the clinic and noted a significant increase in same day
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referrals to the vaccine clinic within the first few days of the project during the post
urgency in service period. The champion started tracking the available doses of the
vaccines in order to prevent a limited supply or delay in administration. Adherence rates
were added to the vaccination data report for my review. Although the adherence data
was not tracked or included in the project outcome assessment as baseline data, the rates
appeared to have meaningful significance showing that 60% (83/138 patients) of the
patients receiving a recommendation for HPV did follow the recommendation given by
their provider. Communities should be educated on cancer prevention as a priority with
HPV vaccination. The healthcare provider should stay up to date on current trends and
speak knowledgably on cancer prevention. No person should suffer the consequences of a
preventable cancer or related treatment, including surgical complications, swallowing
difficulty, depression, pain, infertility, or any of the countless other potential life
changing effects from chemo and radiation therapies (Coley, Hoefer, & Rausch-Phung,
2018). To significantly reduce infections and eliminate HPV-related cancers providers
worldwide must remain advocates for their vulnerable patient populations locally and
globally through education, policy advocacy and by avoiding personal bias and barriers
to recommendation (Sussman et al., 2015). Education frameworks can be used across
disciplines to make the kind of positive and measurable impacts to prevent disease in
nursing, medicine, social sciences, and beyond. Vast positive social changes can be made
to promote health as it relates to sexually transmitted HPV and elimination of associated
cervical and oral cancers locally and globally. HPV infection is pandemic, and the
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intervention will have the potential to make positive impacts on our local, national and
even global communities (Fedewa et al., 2018).
DNP Leaders as Team Members
As a DNP project leader, I was responsible for providing peer reviewed evidencebased practice recommendations to the practice site, communicating effectively with the
medical director and acting as a liaison between the vaccine champion and project
outcomes. I delivered an urgency statement poster and in-service to the medical director
directly on the state of HPV infection and results from the providers surveys and
vaccination data reports were de identified and discussed with the medical director. I
transferred all data from vaccination reports into the Excel spreadsheet and shredded all
project documents myself. Communication with the medical director and vaccine nurse
was imperative throughout the project and was deemed effective by staying on the
projected timeline for project. Outcomes from the project will be shared with the medical
director by providing a copy of the final DNP project paper to the director once the paper
meets committee final approval. Legislative Support is imperative for the advancement of
policies brought forward by advanced practitioners (IOM, 2010). Using the lens of the
McMaster Health Forum or EVIPNet framework the policy does show evidence of being
informed and considers the main opposition stakeholders and supporters as well.
Strengths and Limitations
Although the clinic did not have a way of tracking vaccine recommendations
through the walk-in clinic, I felt it was important to include all providers in the education
framework within this project. All providers, even those working in the walk-in clinic,
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occasionally rotated through the in-office clinic to see patients. Providers working in the
walk-in clinic were included in the barrier assessment and were given the opportunity to
review the urgency statement on HPV. The patients seen in the walk-in clinic were not
included in the total recommendation assessment, but the provider would be prepared to
educate and recommend the vaccine to their patients when they were being evaluated
later in the in-office clinic. While the DNP project was able to demonstrate a quality
improvement outcome for the clinic there were two major limitations in terms of access
to the clinical site providers. First, limited numbers of providers were able to attend the
in-service because the designed program was a one-day presentation and only the
working provider group was able to hear the information on HPV urgency from me. The
rest of the providers were relayed the information through the medical director upon their
return to work. Initially, the project plan was to in service all providers on the HPV
urgency statement through in-service. In service was limited to the provider group that
was on staff the day of the scheduled in-service. The HPV urgency statement was
delivered to the medical director and the in service was delivered to him directly. The full
in-service was not presented to all the providers in the clinic. Because the pre assessment
survey group and post assessment survey group were different groups of providers
comparisons of barriers between groups could not be made. Regardless of these access
barriers the medical director and the vaccine champion did relay all appropriate
information to the staff and the HPV urgency poster was posted in the centralized area. A
mixed methods study evaluated the 15-year trends of cervical and oropharyngeal cancer,
finding that as a result of screening and vaccine the cervical cancers have declined, but
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oropharyngeal cancers have continued to rise (Sussman et al., 2015). A clinician
questionnaire was used to survey external factors and barriers that had potential influence
on vaccination adherence. Sociocultural behaviors, media and policy were evaluated, and
providers reported a variety of challenges to vaccination recommendation. It was found
that only 9% of eligible adolescents received complete series to vaccination.
Recommendations included a set of counseling strategies for overcoming identified
barriers to vaccination recommendation. Researchers found that the results of this study
were consistent with other recently published qualitative research studies (Sussman, et
al., 2015). Clinicians who focused on cancer prevention rather than sexual activity
counseling had a stronger adherence to vaccination (Sussman et al., 2015). The article
supports the DNP project efforts to encourage provider recommendation by reporting the
scientific state of urgency behind rising infection and related mortality. The medical
director and the vaccine champion instructed the providers on appropriate documentation
that was a perceived positive and independent result of the project. While documentation
may be a large part in the overall increase in recommendation rates, it is believed to have
improved the practice process on tracking education and likely will improve
reimbursement from payers, however, the reimbursement improvements were not
evaluated as part of the project.
All data reports and surveys were collected and reviewed during the appropriate
timeline. Overall the goal of increasing provider recommendation to HPV is
demonstrable within this project, as 82 additional recommendations were charted during
the post urgency four-week time period. Secondly, because visits on vaccination
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recommendation were tracked only through the check box system, the clinic was also
unable to track any separate visits that occurred as a result of a walk-in clinic or
vaccination clinic visit. Our project only measured recommendation rates that occurred
through a scheduled visit check box evaluation. Clinics with specialty providers have an
inter collaborative approach and are increasingly likely to appoint vaccine champions,
use standardized policies and schedule appropriate time to visits scheduled for
vaccination (Lollier, et al., 2018). Evidence supports a systems-process-outcomes
evaluation because HPV is not a reportable disease. The CDC has an approved selfsurvey module for providers that has 5 questions on the epidemiology of HPV that will
examine the providers’ knowledge base of HPV and vaccination data that follows the
CDC recommendation (Vaccines CDC, 2019). While the eligible age for HPV vaccine is
9-45 years, the CDC recommends that a two series vaccine be given at least 6 months
apart to 11 and 12-year-old children. Data shows that two series vaccine protects best if
received before age 15 or before sexual activity has started (CDC, 2019).
A limitation to provider recommendation may have been that at baseline the
providers were not told how information on how tracking documentation was relayed to
the project leader. If the providers were recommending HPV vaccine before the project,
but were not documenting through the checkbox system, the poor tracking could have
been an explanation for why the rates of recommendation were reported to be so low
(3%). The American Cancer Society addresses the problem of poor provider vaccination
rates/recommendations by working as a direct partner in health initiatives and program
development in collaboration with CDC. A new set of initiatives have been created and
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approved with new goals for vaccination of HPV focusing on reaching 80% adherence by
2026 (Fedewa et al., 2018). The HPM considers how behavioral factors within the
provider population affects whether the provider makes the recommendation to vaccinate.
Providers may have their own personal beliefs or opinions that present as barriers to
recommendation for HPV vaccine. Pender’s HPM applies theory to address the
disparities in health between males and females in receiving HPV vaccination.
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Section 5: Dissemination Plan
Introduction
The multispecialty clinic has demonstrated the importance of the assessment of
barriers toward vaccination using the Social Cognitive Theory and Pender’s HPM to
measure how education influences provider rates of recommendation to create change in
the outpatient setting. Measurably higher rates of HPV vaccine recommendation occurred
in educational frameworks. Clarifying the audiences and venues that would be
appropriate for dissemination the QI project enables me to make impacts to the broader
nursing profession and healthcare’s social platform in our community. In Section 5, I will
discuss how the DNP project will define how I may translate the QI findings into
meaningful application into clinical sites and within the nursing profession. The QI
outcomes proved to have public health implications toward prevention of disease and
associated cancer. The focus for forward movement in change will be in policy advocacy
and creation of legislation around vaccination and provider documentation platforms.
Institution Plan
The final DNP project results were shared with the medical director overseeing
the project. All documents, surveys, and deidentified worksheets were reviewed by the
director before the findings were summarized. Specifically, I reviewed the figures that I
created for the Findings and Implications section of the project showing how the
vaccination recommendations increased after education. The figures created to explain
provider barriers were also reviewed with the director. Our meeting was a brief one-onone interaction, and the figures aided me in delivering a timely and poignant review of
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the outcomes of the study. I provided the medical director with a copy of the figures to
share with the clinical practice group. The key to ensuring the project results were
representative of the evidence meant that I was able to translate the findings in a
meaningful way. Stakeholders and end users within any health care practice area must
demonstrate the ability to recognize practice problems and translate evidence into
solutions (Leung, Trevana, & Waters, 2014).
Nursing Profession Dissemination
The ANA 2014 described how advanced nursing leaders are especially equipped
to translate research into clinical practice by using patient centric advocacy, education
and leadership to improve healthcare delivery to patients and communities. I have used
the DNP essentials to explicitly gain liaisons in healthcare to bridge the gaps in
knowledge and policy toward improved patient care outcomes. My DNP project mentor
and I have used the research to show the need for change in vaccination efforts and
recommendation in providers within our community. The focus on HPV vaccination has
turned from prevention of an STD to a cancer prevention modality. Although advanced
practice nurses understand the ongoing barriers that exist in our state and our nation, we
also are increasingly equipped with ways to overcome these barriers. The nursing
profession stands as the base I may rely on to have my voice heard in a post empirical
viewpoint. Placing nursing professionals at the forefront of education makes them a
crucial part of the Workforce Development team to help address disparities in cancer
related HPV prevention strategies (Senkomago et al., 2017). Senkomago et al. (2017)
described how despite rural and low-income countries having lack of access barriers, the
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Global Initiative for Cancer Registry Development has a goal to reach 150 countries
participating in advocacy and collaboration networks. HPV has been identified as the
cause for nearly all cervical cancers, some of the vaginal cancers and most oropharyngeal
cancers around the world (Senkomago et al., 2017). As HPV infection and related cancers
are continuing to climb, global initiatives for surveillance and vaccination are becoming a
priority (Senkomago et al., 2017).
Analysis of Self
Practitioner
Using program evaluations sets the framework for the DNP who are positioned to
move change forward, create buy in, and implement leadership by calling on assimilated
program design and programs to bridge gaps in systems and demonstrate the need for
change (Pritham, 2016). An example of a QI program design is knowing how to develop
validated or standardized tools and incorporate those into practice settings. The CE
module from the CDC tool has been validated in the literature and now is translated to
use through the vaccination recommendation process and is considered a program design
and evaluation. As a practitioner, I often used technology and HIT frameworks to
document my care. Through the DNP project, I have come to understand how HIT
develops standards to track and evaluate both disease specific data and tracks provider
treatments and standard of care delivery. If the urgency statement on HPV is validated
into an electronic platform, the data can be tracked from provider to provider and the
system could even drive outcome measures to patient knowledge setting the bar for the
level of understanding required before undergoing vaccination (Sherrod, & Goda, 2016).
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There are cost-reduction implications to these systems that have yet to be evaluated as
part of DNP project.
Scholar
As with the other quality improvement projects I have worked on throughout the
practicum, using QI methodology proved to have positive effects on my ability to
demonstrate leadership and create change. I have always valued the transformational
leadership skills that come from being able to show how research and validated tools may
be implemented into practice. For the practicum this term, the leadership strategy behind
research translation and collaboration reached new application. The research that I did on
HPV vaccination strategies was shared with my mentor. Dr Carlson is a speaker for the
Head and Neck Maxillofacial Department and was a guest speaker for the Big 4 Cancer
Conference held in the region where he delivered a speech on HPV-related cancers and
cited my research to deliver up-to-date status on the infection and prevention strategies. I
feel that I have been able to share my knowledge on research translation and effective
collaborate in a multidisciplinary way throughout the DNP project. The DNP as a policy
developer holds a key position as part of the healthcare team and should understand
current policy and barriers to work on topics such as vaccination before moving forward
to make a stance against or for a purposed change (IOM, 2010). Tenn. Code. Ann 68-10104 aims to give Tennessee adolescents care for STDs upon diagnosis but does not
explicitly state vaccination as part of STD prevention or cancer prevention as an option to
access (English, Bass, Boyle, & Eshragn, 2010). The Tennessee Attorney General has
worked with Tennessee to define a “mature minor rule” for personal consent allowances.
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The rule states that minors between the ages of 14-18 have a specific “capacity to
consent” for treatments centered around contraception, prenatal care, STD treatment and
screening, and drug and alcohol addiction (English et al., 2010). As a DNP student
scholar, I have come to understand how transformational leadership may aid in the
translation of EBP to clinical practice. Guidelines of transformational leadership suggest
that new practice standards should include development of a team developed vision
statement for clinical practices. The use of a vision statement in PICO format supported
engaging nonbiased care and provided leaders a framework to deliver the essential
characteristics of education and recommendation toward vaccination. Applying empathy
towards healthcare workers translated into inspiring quality care delivery to patients
(Abdullah et al., 2014).
Project Manager
The Future of Nursing Report from the IOM aims to provide support for ongoing
education and quality improvement projects that can measure positive patient outcomes
(IOM, 2010). In the DNP project, I believe managing the project on HPV vaccination
recommendation helped the project site toward application and evaluation of their
personal delivery style of HPV vaccination information and helped them adjust to gaps in
knowledge of personal bias. The pre- and post-education survey tool was a
nonthreatening way to measure barriers to vaccine recommendation without penalty. In
today’s healthcare model of declining reimbursement identifying strategies to improve
delivery is an important support needed for providers. The multidisciplinary efforts in the
primary provider HPV vaccination recommendation project were helpful to me as a DNP
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student. My leadership style allowed for increased collaboration efforts to be
implemented and helped the attending doctor see how the utilization of a team in teaching
was better than a single NP project initiative. The additional support of the team members
was vital to the success of the project. The clinic does not use an electronic tracking
system in all ancillary clinics, which is a major limitation to measuring outcomes and
demonstrating tool effectiveness to stakeholders for ongoing projects. Whereas if the
EHR was implemented in all branches of the clinic and not solely the routine office visits,
the information and effects on outcomes would be more easily shown.
Challenges and Insights
Project barriers of lack of knowledge and time were the main provider focused
barriers to implementation of the project. However, providers support the idea of
transcending self-awareness and team approach that is required for change (LeonardMcRae, 2017). The EBM used current knowledge, skill level, and attitude assessment
through psychological questionnaires to develop the need for common barriers to
recommendation to HPV vaccine in practice. By using the HPM Model,
Transformational Leadership and EBM the practice can continue patient improvement
outcome measures, apply knowledge translation by developing a common vision
statement and recommendation and reduce variation in care delivered creating strong
interpersonal relationships and positive workplace culture (Leung et al., 2014). In quality
improvement change projects, success or failure comes from internal factors that include
the project leader’s ability to demonstrate urgent vision, engage other leaders, gain
resources toward change and demonstrate measurable outcomes (Solberg, 2007). Solberg
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2007 explains how transformational program design is crucial to the success of patient
centric change. For pedagogical intervention in the population of multispecialty providers
to show a way to measure improvement in outcomes and is geared toward engaging
systems, employee and patients alike toward change. QI projects, when done effectively,
increase levels of knowledge in the patient. The strategies toward inter professional
collaboration were strongly implemented with stakeholders on this project including IRB,
clinical providers, medical director MD, the vaccine champion nurse and APN and
patient revealing potential benefit for ongoing research (Braithwaite et al., 2013)
Patient centered care integration relates to programs that increase efficiency and
quality (Garcia, et al.2019). DNP professionals measure, document and evaluate the
effectiveness of recommendation, therefore, effectively follow a quality improvement
methodology. There are no directly visible barriers within the context of the project site
as all stakeholders demonstrated acceptance for the project and assessment process.
Funding around movement to EHR checkbox systems was not discussed in ongoing
change projects. The project facility has adopted an EHR to comply with CMS
meaningful use guidelines, therefore, any additional electronic support would be easily
incorporated into the existing system despite some additional costs.
Summary
It was the aim and purpose of the DNP project to use an educational framework to
assess a QI outcome toward provider recommendation rates toward HPV vaccination.
The project did reveal a QI outcome in the multispecialty clinic site revealing compelling
data that links higher rates of recommendation toward vaccination in provider groups that
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receive a framework in which to become educated about HPV vaccination. The urgency
statement developed for the project provides support from resources validated by the CE
module from the CDC and ACS initiatives. The Healthy People Goals of 2026 serve as a
reminder for clinicians in multispecialty clinics to refer to in efforts toward vaccination
recommendation that encourages all adolescents receiving vaccination before their 13th
birthday (Fedewa et al., 2018). The urgency statement created for this project
incorporates all current state of science on HPV vaccination as a primary cancer
prevention strategy. As HPV-related cancer incidence continues to climb and
transmission of disease has reached 45% of the adult population in the US, the urgency of
HPV vaccination is requiring translation to practice strategies like those suggested in the
HPM pedagogy applied for our project (Senkomago et al., 2017). It has been projected
that nearly all sexually active adults will have been exposed to HPV in their lifetime and
now is the time for prevention through vaccination to become a national standard to care
here in the United States and abroad. There is a direct and measurable link between
recommendation for HPV vaccination and adherence to the vaccine (Niccolai et al.,
2018). If vaccination adherence reaches the 80% rate it is predicted that essentially all
HPV infections will be eradicated, and HPV associated cancers will be reduced to less
than 20% globally (Niccolai et al., 2018). Social change through quality improvement
can be directly measured in the case of HPV vaccination recommendation.
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Appendix A: WD4019: You Are the Key to HPV Cancer Prevention-2018
1.

2.

3.

4.

5.

The perceived and real concerns of parents influence how clinicians recommend the HPV
vaccine toward
A. HPV, Tdap, meningitis
B. Hep B, Tdap, meningitis
C. HPV, Hep B, Tdap
D. Other adolescent vaccines, pertussis, Hepatitis, HPV
Some parents may still be interested in vaccinating yet still have questions. Ask parents about
their main concerns and use the You Call the Shots self-study modules offering responses
A. Parental attitudes “We’ll give the shots at the end of the visit. Do you have any
questions for me?’
B. Low perceived benefits “We can help prevent infection types of HPV that can cause
cancers by starting the vaccine series today”
C. Social Influences “HPV vaccination is important because it prevents cancer” &
“HPV vaccine does not make your kids more likely to engage in sexual activity”
D. Concern for adverse reactions with vaccinations “I have researched the HPV vaccine
including safety. Can I share with you what I’ve learned?”
E. Irregular preventative care “When you check out please make an appointment for 6
months from now.”
HPV has been linked to cervical cancer in women and oropharyngeal cancer in women and
men, in evaluating trends from the years between 2014-2019
A. Cervical Cancer is continuing to rise, While Oropharyngeal has decreased
B. Cervical and oropharyngeal cancers continue to rise
C. Cervical cancers have decreased while oropharyngeal cancers continue to rise
D. Both cervical and oropharyngeal cancers are now on the decline
There are concerns about safety related to vaccination. The CDC is supported by:
A. Reactions may include ever, headaches and injection site redness and pain
B. HPV vaccines are safe
C. Brief fainting spells (syncope) can occur after any injection including HPV
D. Patients should be sitting (or lying) during the injection and remain that way for 15
minutes
Explain the recommendations for HPV vaccine to adolescents and their parents by:
A. Boys and girls aged 9-14 should receive HPV vaccine (series of 2) or if 15 or older
(series of 3) to prevent cancer regardless of sexual activity status.
B. Boys and girls should receive the vaccine before their 13th birthday
C. The HPV vaccine (series of 2) should be given to all eligible adolescents age 11-12
years old, with the second dose given 6-12 months from the first
D. Boys and girls can start the vaccine at age 9

www.cdc.gov/vaccines/ed/hpv/you-are-key-2018.html
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Appendix B Literature Review Matrix
Author/Date

Theoretical/
Conceptual
Framework

Research
Question(s)/
Hypotheses

Methodology

AttipoeDorcoo, S.,
Singh, V., &
Moodley, J.
(2018).

Vaccination
programme
analysis

Cervical
cancer
leading cause
of cancer
related
deaths in
women in
South Africa

Cole, T.,
Thomas, M.
C., Straup,
K., &
Savage, A.
(2017).

Education
platform
based on the
Health
Promotion
Model to
assess
barriers and
develop
strategies to
overcome

Will
identifying
barriers and
assign
strategies
help to
reduce the 79
million cases
of HPV and
prevent the
14 million
new cases
every year

Mixed
Includes
interviews,
surveys on
provider
education and
parental/patien
t knowledge

Drolet, M.
(2015).

Grounded
Theory

Is HERD
immunity
making an
impact by
vaccinating
girls for HPV

Fedewa, S.
A., Preiss, A.
J., Fisher, B.
M., Goding
Sauer, A.,
Jemal, A.,
Saslow, D.,
& FisherBorne, M.
(2018).

American
Cancer
Society
Goals 2026
Using HPM
and
Behavioral
Theory

HPV vaccine
prevalence to
80% of 1113-year old’s
receive
vaccine to
reduce
associated
cancers

Analysis &
Results

Conclusions

Implications
for future
research

Implications
for practice

News Reviews Articles
Quantitative
significantly
Methods
described
efficacious
vaccine but
did not
mention or
describe side
effects

Positive and
accurate
media
campaign in
South Africa
but
sometimes
incomplete/
Vaccine did
not change
sexual
behavior
patterns in
young girls

Continued
need for
research on
how
providers
may impact
social
acceptance

Parental
consent was
still applying
barriers so
education
must
continue in
practice
setting

Results show
improved
vaccination
rates in
centers with
developed
education
methods

Higher
vaccines rate
occurs when
education is
done, and
barriers
strategies are
implemented

Need to
continue to
identify
which
strategies are
most
effective and
most cost
effective

Cost
effective
methods
need to be
analyzed
with time
required to
make
significant
impacts

Systematic
positive
Review and
Meta-Analysis

Herd
immunity
concepts do
make
statistical
improvement
s in HPV
infection

Will cancers
in men be
eradicated by
herd
immunity

Limitations
exist in Herd
because of
dormant
HPV
infections
causing
cancers in
those not
vaccinated
during preadolescent
age

Mixed
Focus on
Surveys NIS
cancer
for Teens and prevention
estimating
numbers of
pre-teens
required to get
to 80% goal.

An
additional
7.62 million
males and
6.77 million
females
would need
to receive the
vaccine
between
2018-2026 in
order to
achieve the
80% goal (p.
4720)

To reach the
goal provider
recommendat
ion and
parental
acceptance
must be
increased

Education
and
knowledge
development
tools within
the research
need to be
ongoing to
reach this
goal
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FisherBorne, M.,
Preiss, A. J.,
Black, M.,
Roberts, K.,
& Saslow, D.
(2018)

Primary Care
Workforce
developed
for
(FQHC’s)

Vaccine
project
outcomes
measured for
effectiveness
to increase
HPV vaccine
in FQHC

Quantitative
methods
measured HPV
vaccine
completion
rates for
centers in the
FQHC after
receiving
grants to do so

Initiation
rates for
HPV vaccine
increased
significantly
by 14.6 %
points but
were not
statistically
improved for
the second
vaccine in
the series (p.
S79)

Highly
successful
initiation
project for
vaccine

Other
vaccines
including
tetanus,
diphtheria
and
Meningococc
al adherence
was also
improved so
vaccine
projects in
research

QI projects
are
expanding
for
increasing
HPV vaccine
efforts due to
the results of
these
programs*

Haddad, N.,
Allen, R. H.,
Szkwarko,
D., Forcier,
M., &
Paquette, C.
(2018)

Grounded
Theory

Eliminating
parental
consent for
HPV vaccine

By using Title
X patient
Authority

Teens can be
screened to
obtain OCP
without
parental
consent (p
12)

Successful
programs in
schools have
been
demonstrated
to reach
>80%
adherence

Comparing
this vaccine
to others that
have
different
timing like in
infancy
improves
Hep B
vaccine rates

Policy
changes may
enable the
schools to
implement
vaccine
programs or
remove
parental
consent for
in office
patient
driven
vaccine
related
knowledge

Lollier, A.,
Rodriquez,
E., SaadHarfouche,
F., Widman,
C., Mahoney,
M. (2018).

HPM and
behavioral
care

Evaluation of
high and low
performing
PCPs

Mixed
Advisory
Committee
Research and
provider
interviews and
surveys to
barriers

Offices with
higher rates
of vaccine
adherence
had more
full-time
staff and
designated
clinical
champions

Advisory
Committee
recognizes
and supports
the four
major
vaccines
Tdap,
meningitis,
flu and HPV

Research on
providers
overcoming
barriers in
research

Implementin
g research in
practical
ways to
remove bias
and improve
access of
care required

Sussman, A.,
Helitzer, D.,
Bennett, A.,
Solares, A.,}
Lanoue, M.,
& Getrich, C.
(2015)

Behavioral
Model
Survey

Vaccination
rates are still
not being
achieved
despite
strong
clinical drive

Mixed,
qualitative indepth
interviews
with clinicians
and policy
makers and
confirmatory
surveys

Greatest
barrier to
vaccine was
lack of
tracking and
health
delivery
challenges
not
sociocultural
identifiers

Interventions
targeting
communicati
on and
education are
priority to
improving
vaccine

In depth
research has
evaluated
education
and
strategies to
promote
vaccine

Utilization of
other venues
outside of
clinics must
be made to
reach a
greater
community
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Appendix C: HPV Urgency Statement for Multispecialty Providers
1. Appreciate the significance of meeting the CDC’s HPV vaccination
recommendation rate of 80%. Human Papillomavirus (HPV) is the most common sexually
transmitted disease in the United States in 2018 (Van Dyne et al., 2018). The Centers for Disease
Control and Prevention (CDC) established the Healthy People 2020 initiative for HPV vaccination
uptake of 80% in effort to effectively eliminate the HPV associated cancers. Both men and women are
being diagnosed with HPV related cancers despite health care initiatives and provider awareness
campaigns. With 14 million new cases per year in the United States alone, the American Cancer
Society has made new a new goal for the year 2026 that would support that 80% of pre-teens 11-12
years old will receive the vaccine before their 13th birthday (Fedewa et al., 2018).

2. Acknowledge the importance of your recommendation and considered bundling
your recommendation with the other age-related school entry vaccines. The tdap,
meningitis, and flu vaccines all have adherence rates greater than 80% The World Health Organization
(WHO) data demonstrates that despite vaccination efforts and screening these numbers are now
globally reaching 570,000 HPV related cancers in women and 60,000 cancers in men per year (St.
Laurent, Luckett, & Feldman, 2018). If vaccination rates reach the 80% goal, vaccine models suggest
that the HPV infection would be completely eradicated, and cancer deaths could be reduced to 20%
globally (Brisson et al., 2016).

3. Motivate your team and include parents on the discussion around HPV
vaccination as it relates to HPV related cancers. HPV has been identified as the cause for
nearly all cervical cancers, some of the vaginal cancers and most oropharyngeal cancers around the
world (Senkomago et al., 2017). As HPV infection and related cancers are continuing to climb, global
initiatives for surveillance and vaccination are becoming a priority (Senkomago et al., 2017).
Clinicians using a thematic approach to evaluate the social impacts and barriers to HPV vaccination
recommendation find that a strong recommendation from a provider is highly motivating for the parent
and patient in terms of vaccination adherence (Niccolai, North, Footman, & Hausen, 2018). When
addressing anti vax concerns and issues about side effects try stating “I have researched the HPV
vaccine including safety. Can I share with you what I’ve learned?”

4. Know your rates of recommendation and refusal so you may help develop
solutions to barriers. Locally the public commissioner of health and the CDC have reported that
while nationally HPV vaccination rates among eligible adolescent patients are recorded at 40%, our
state records an even lower uptake of vaccination of 30% (HPV Vaccines, 2018). The problem of HPV
infection is reaching 45% of the US population and is anticipated to grow if states do not react to find
vaccination compliance strategies (HPV Vaccines, 2018). The Mid-Atlantic region falls along a
religious beltway in the United States that sets precedent for religious beliefs to impact vaccination
adherence. The religiously exempt students make up the largest group of unvaccinated kids in the
county with just under 2% claiming this exemption (Capps, 2019). The County Health Department
reports that there are higher numbers of parents reporting lack of access to care related to time and
travel to care centers compared to anti vaccination philosophies (Capps, 2019 para. 7). The clinics
approximate current recommendation rate is 3%.

5. Understand how to overcome barriers to HPV vaccine. The federal initiative for public
health on HPV vaccination is called the Hub and Spoke Initiative (American Academy of Pediatrics

91
[AAP], 2019). In a collaboration with the CDC and the AAP the Community Guide and the Hub and
Spoke Initiative were formed. The priority of the Hub and Spoke Initiative is to focus on creating peer
guided accountability on strong provider recommendations for vaccination against HPV (AAP, 2019).
The cultural, ethical, and legal obligations to promote wellness through vaccination becomes
imperative in the framework of preventing the spread of HPV infection, because infections are directly
related to higher risk for cancer (AAP, 2019). With any illness that is spread due to sexual
transmission a stigma and fear may present, not just in the parental community, but the provider one as
well (Fedewa et al., 2018). The National Committee of Immunization and Research (NCIR) and the
Advisory Committee on Immunization Practices (ACIP) have defined evidenced based guidelines for
HPV vaccination that the CDC used to create the module (Health and Human Services, 2019). The
CDC has a wide scope initiative for HPV vaccination and program that includes references and tools
for clinicians contained in the HPV Toolkit and has an assigned approved Office of Management and
Budget (OMB) # 0990-0379 (Health and Human Services, 2019). The tool includes five major item
sections of content that measures learning objectives in the areas of HPV vaccine as cancer prevention,
indications for the vaccines in boys and girls, components of vaccine recommendations, relevant and
compelling information on the vaccine for parents, and disease prevention risks and strategies (Health
and Human Services, 2019). In efforts to identify the barriers to meeting vaccination rates community
leaders around the world have made poor HPV vaccination rates a global pandemic priority (Fedewa et
al., 2018). Cervical cancer has trended downward in the last fifteen years, but cervical and oral cancer
diagnoses continue to reach numbers larger than 500,000 per year (Senkomago et al., 2017). There is
significance in HPV vaccination as a public health problem because after more than a decade of HPV
vaccination awareness, providers are still coming up short with recommendations to vaccinate
(Niccolai, et al., 2018). Recommendations to vaccinate have been identified as the most significant
predictor of vaccination adherence among the pre-teen population (Niccolai, et al., 2018).

*This statement was developed using resources from the CDC HPV Toolkit, CE
Module: WD4019: You Are The Key To HPV Cancer Prevention 2019, Health and
Human Services Public Access Article (Holman et al., 2015) and the DNP Project
Literature Review titled “Primary Provider Education Increasing Knowledge and
Recommendation for Human Papillomavirus Vaccination “and the American
Academy of Pediatrics 2019.

